* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download Cardiovascular System
Heart failure wikipedia , lookup
Electrocardiography wikipedia , lookup
Cardiovascular disease wikipedia , lookup
Lutembacher's syndrome wikipedia , lookup
Management of acute coronary syndrome wikipedia , lookup
Cardiac surgery wikipedia , lookup
Coronary artery disease wikipedia , lookup
Antihypertensive drug wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Dextro-Transposition of the great arteries wikipedia , lookup
Cardiovascular System 10 January 2012 14:02 Guide for use of these notes Definitions First of all thank you for choosing to download these notes to study from I hope you find them useful, please feel free to email me if you have any problems with the notes or if you notice any errors. I don't promise to respond to all emails but I'll do my best. Afterload- Weight not apparent to muscle in resting state, only encountered upon contraction of the muscle. For the cardiovascular notes I used "Vander's physiology" and "Systems of the BodyCardiovascular System" Cardiac afterload- The afterload on the heart is the load against which the left ventricle ejects the blood after the opening of the aortic valve. I organise my notes so that you should read the learning objectives on the left then proceed down the right hand side for a few learning objectives and then cross back over to the left and continue like that. Calcium transient is the rise and fall of calcium during contraction. Anything in this highlighted green is a definition or explains basically something's function. Text highlighted in yellow or with a star is what I would deem important and key to your information. Italics and bold just help to make certain terms stand out. The notes are a bit quirky but I hope you like them and find some of the memory aides strange enough so that they stick in your head. I provide them to you in OneNote format as that is how I created them, they can be saved as PDF but the formatting is not as nice. The one caveat with this is that these notes are freely copy able and editable. I would prefer if you didn't copy and paste my notes into your own but used them as a reference or preferably instead embellished these already existing notes by adding to them. Good luck with first year Stuart Taylor Stuart's Cardiovascular System Page 1 Frank-Starling Relation- Increased diastolic fibre length increases ventricular contraction. Think preload. Law of Laplace- When the pressure within a cylinder is held constant, the tension on its walls increases with increasing radius. Mean frontal plane of the ventricles- Mean direction of depolarisation is to bottom right- due to needing more current to polarises greater size of wall of left ventricle. Preload- The weight acting on a muscle that stretches it before it is stimulated to contract. Stroke Volume- In cardiovascular physiology, stroke volume (SV) is the volume of blood pumped from one ventricle of the heart with each beat. Anatomy of the heart and circulation 17 January 2012 14:02 Learning Objectives Identify the pericardium in the cadaver and describe its organisation Demonstrate the four chambers of the heart List the vessels that enter or leave each of the chambers of the heart Identify the origin of the brachiocephalic artery, the Subclavian arteries and the carotid system of arteries in a cadaver Describe the position and relations of the aortic arch and descending aorta Explain how blood returns from the head and neck to the heart Identify the superior vena cava in a cadaver Outline the coronary circulation and be able to identify the main coronary arteries and cardiac veins Identify and label the heart valves and their locations, and state the structural similarities and differences Explain how blood leaving the heart reaches (a) head and neck, (b) lungs, (c) thoracic and abdominal cavities Describe the components of the conduction system Identify the origin of the brachiocephalic artery, the subclavian arteries and the carotid system of arteries in a cadaver Identify the pericardium in the cadaver and describe its organisation • The pericardium is located within the Inferior Mediastinum- the cavity that is between the two pleural cavities. The heart is contained within pericardium which is a fibrous sac and is stuck to the diaphragm and therefore moves during breathing. • Mesothelial cells line the inner pericardium. Two layers of pericardium: • Fibrous pericardium that stops expansion. • Serous- Has some fluid with it. Two layers itself i. Parietal- lines fibrous ii. Visceral- adheres to heart. Demonstrate the four chambers of the heart List the vessels that enter or leave each of the chambers of the heart Systemic circulation is to the body Pulmonary circulation is to the lungs Pulmonary trunk forms T shape due to vessels having to go to both lungs. Arch travels leftwards and backwards RA= Vena cava RV= Pulmonary artery LA= Pulmonary vein LV= Aorta • The brachiocephalic trunk is an offshoot of the ascending aorta. • In terms of blood supply there is a necessity for having 4 arteries in order to supply both upper limbs and both sides of the brain. • Anatomically only one brachiocephalic trunk is needed because the arteries are going in the same general direction with the aorta. • When referring to arteries or veins etc. the term common means that the blood vessel is likely to divide. Explain how blood returns from the head and neck to the heart Identify the superior vena cava in a cadaver Identify and label the heart valves and their locations, and state the structural similarities and differences • There are 2 brachiocephalic veins in comparison to the one brachiocephalic artery/trunk. • The 2 brachiocephalic veins are formed from the subclavian vein and the jugular vein. These join with the superior vena cava and enter the right atrium of the heart. • There are 3 main types of valve within the human heart. • These are: 1) The tricuspid valve on the RHS of the heart. 2) The mitral (bicuspid) on the LHS of the heart. 3) Semi-lunar valves which stop back flow of blood from vessels leaving the heart. • The first two valves are collectively known as the Atrio-Ventricular valves. • On a side note the snapping shut of the aortic semi-lunar valve gives the second sound of the heart beat. • For better version of second heartbeat look herehttp://www.youtube.com/watch?v=gvLmrCXjUuU • Good memory note for remembering which side is which is "Try before you buy" as if you were looking at a diagram of the heart. • Supraventricular crest is a muscular ridge that separates/ regulates the effects of the tricuspid and pulmonary valves. The supraventricular crest is a circular muscular ridge on the inner wall of the right ventricle, separating its inflow and the outflow aspects (i.e. the tricuspid and pulmonary valves. Source: Medcyclopaedia. • Tricuspid valve has 3 cusps: First. Anterior cusp Second. Septal cusp Third. Posterior cusp • Mitral valve has 2 cusps: Stuart's Cardiovascular System Page 2 Outline the coronary circulation and be able to identify the main coronary arteries and cardiac veins First. Anterior cusp Second. Septal cusp Third. Posterior cusp • Mitral valve has 2 cusps: Outline the coronary circulation and be able to identify the main coronary arteries and cardiac veins First. Anterior cusp Second. Posterior cusp • Posterior interventricular is given off by right coronary artery. • Anterior interventricular is given off by left coronary artery. • Tendon like structure are called (Chordae tendineae) these prevent the valve from prolapsing under the pressure of the back flow of blood. • An analogy the lecturer used was to think of these cords like the cords of a parachute- by pulling down on them you stop the parachute tarpaulin from inverting due to air resistance. LHS of Heart The Coronary sinus is a vein that drains the heart. Describe the components of the conduction system • Sinoatrial node this is the pacemaker of the heart. • Atrioventricular node- Collection of contracting myocytes • Coronary arteries are supplied by blood that comes out of the aorta. • The blood that collects in the semi-lunar cusps is delivered to the coronary arteries at diastole upon back flow of blood. • Out of the three semilunar cusps 2 supply coronary arteries and the posterior is a non-coronary sinus. • The sinuses on the RHS of the heart are the right, anterior and left cusps. • Coronary veins drain into right atrium Qu. 1: In the normal adult what is the name of the oval depression in the right atrium where the septum is thin? Foramen ovale √ Oval fossa Ligamentum arteriosum Supraventricular crest Moderator band √ Mark = 1 (conf=1 ) Best Option: Oval fossa Foramen ovale is the term used in the foetus. Lecture: Chambers,valves, conduction system and coronary circulation Pasted from <https://www.ucl.ac.uk/lapt/laptlite/sys/run.htm?icl08_cvs1?f=clear?i=icl1?k=1?u=_st1511?i=Imperial> • 3 nodal tracts going from the SAN to the AVN which are: ○ Anterior nodal tract ○ Middle nodal tract ○ Posterior nodal tract Qu. 7: What is meant by the term 'right coronary dominance'? X Right coronary artery supplies more blood than left coronary artery to heart Right coronary artery receives a greater supply from posterior descending coronary artery Stuart's Cardiovascular System Page 3 Qu. 6: Which of the following components of a blood vessel contains a small network of blood vessels called the vasa vasorum? X Right coronary artery supplies more blood than left coronary artery to heart Right coronary artery receives a greater supply from posterior descending coronary artery Right coronary artery supplies posterior descending coronary artery Right coronary artery does NOT supply posterior descending coronary artery Right coronary artery branches more than left system X Mark = -2 (conf=2 ) Best Option: Right coronary artery supplies posterior descending coronary artery In 85% of cases, the right coronary artery (RCA) is a dominant vessel and supplies the posterior descending branch that travels in the posterior interventricular groove. Source: cardiologysite.com/html/rca/.html. A.S.M Systems, 2007. Qu. 6: Which of the following components of a blood vessel contains a small network of blood vessels called the vasa vasorum? √ Adventitia Elastic lamina Media Intima Valves √ Mark = 1 (conf=1 ) Best Option: Adventitia The adventitia is the outer layer of connective tissue and nerve fibres that contains a small network of vessels called 'vasa vasorum'. Elastic lamina= layers of elastic fibres in vessel walls - internal layer below intima, external layer between adventitia and media. Media= smooth muscle (strength) and muscle fibres (elasticity). Intima= endothelial cells and connective tissue. Pasted from <https://www.ucl.ac.uk/lapt/laptlite/sys/run.htm?icl08_cvs1?f=clear?i=icl1?k=1?u=_st1511?i=Imperial> Pasted from <https://www.ucl.ac.uk/lapt/laptlite/sys/run.htm?icl08_cvs1?f=clear?i=icl1?k=1?u=_st1511?i=Imperial> Stuart's Cardiovascular System Page 4 Mechanical Action of Heart 25 January 2012 10:07 Learning Objectives Explain how calcium influences the heartbeat List the sequence of events from excitation that bring about contraction then relaxation of a ventricular cell Use a graph to compare the length-tension relationships for cardiac and skeletal muscle Explain the concepts of preload and afterload Explain how calcium influences the heartbeat • Calcium transient is the rise and fall of calcium during contraction. • Unlike in skeletal muscle external calcium is necessary for the contraction of the myocytes and thus the production of the heartbeat. • Reminder- Invagination in ventricular cells are t tubules. These carry surface depolarisation deep in the cell. T tubule lies alongside each Z line of a myofibril. • The sarcoplasmic reticulum is the organelle where the internal calcium is stored. Despite being very important it is relatively small and only occupies about 4/5% of total cell volume. State Starling’s Law of the Heart List the sequence of events from excitation that bring about contraction then relaxation of a ventricular cell Explain the mechanisms underlying Starling’s Law of the Heart Excitation- Contraction Coupling of the heart Describe the relationship between ventricular wall tension, chamber radius, and chamber pressure (Law of Laplace) Use a graph to compare the length-tension relationships for cardiac and skeletal muscle Ca Cardiac Muscle: Ca Active force production Isometric (no shortening) contraction Ca Force Passive force A B C Muscle length Force transducer doesn’t allow shortening of the muscle 1. The presence of an action potential that passes down the t-tubule causes an increase in the permeability of L-type (long lasting) Calcium channels. These calcium channels are in fact modified versions of the dihydropyridine receptors that are required for excitation-contraction coupling in skeletal muscle. 2. As the concentration of calcium is higher outside a cell calcium floods in. 3. Calcium then either: ○ Causes the release of further calcium from the Ryanodine receptors which are calcium channels of the Sarcoplasmic Reticulum. This stage is known as Calcium induced, calcium release (CI, CR) ○ Or binds straight to the myofibrils (Troponin C) 4. The next stage involves the removal of calcium and its transport back to the SR for storage. This is done by the enzyme Ca ATPase. The muscle will now relax. 5. In order to maintain calcium balance, calcium that entered at the start must be removed. This is performed by a Na/Ca Antiporter (Exchanger) whereby the influx of sodium with its concentration gradient allows the efflux of calcium against its own. • Inotropic effect/noradrenaline will increase the length calcium channels remain open. Peculiarities of Calcium and Neuromuscular contraction: • From the above description it seems obvious that an increased calcium concentration intracellular should increase force of contraction. This is true see below: • Cardiac muscle is more resistant to stretch and less compliant than skeletal muscle. This is because of the differing properties of extracellular matrix and cytoskeleton. • Furthermore on a physiological basis there is not enough blood supply to the heart to allow prolonged stretching and furthermore it is limited anatomically by the surrounding pericardium. • Only the ascending limb of the relation is important for cardiac muscle i.e. 0-100% muscle length. Explain the concepts of preload and afterload • The heart uses two forms of contraction. The first is isometric- this is where a force is produced without muscle fibers actually shortening. Isotonic is where fibers actually shorten. Refer to Mechanical Action of the Heart 2 for more detail. • Preload- The weight acting on a muscle that stretches it before it is stimulated to contract. • Afterload- Weight not apparent to muscle in resting state, only encountered upon contraction of the muscle. Stuart's Cardiovascular System Page 5 • And likewise in cardiac muscle with extracellular calcium concentration- But its not. • Extracellular calcium is not only used in muscular contractions but also in the propagation of action potentials. Calcium affects the membranes permeability to sodium and a low calcium ECF concentration causes an influx of sodium bringing the membrane close to the threshold. Thus low ECF (hypocalcaemia) causes neuromuscular hyperexcitability. • One has to understand that we are talking about the effects of 2 different calcium pools, one intracellular and the other extracellular. Reference- Human Physiology by Lauralee Sherwood State Starling’s Law of the Heart • Frank-Starling Relation- Increased diastolic fibre length increases ventricular contraction. • Ventricles pump greater stroke volume so that, at equilibrium, cardiac output exactly balances the augmented venous return. • Think!- If blood kept coming into the heart but the ventricles didn't expel the same amount then things would fudge up and become unbalanced. Explain the mechanisms underlying Starling’s Law of the Heart • There are two main mechanisms that influence this relationship 1) Number of myofilament cross bridges that can form. 2) Changes in myofilament sensitivity to Ca. Cross Bridges Further graphs outlining the concept of pre and afterload Isometric (no shortening) contraction Force Preload (stretch) Isotonic (shortening) contraction Calcium Larger preload • Calcium binds to the thin filament protein troponin C. • At longer sarcomere lengths the affinity of troponin C is increased with regards to calcium which means that less is required to achieve the same amount of force. Small preload Velocity of shortening Shortening Afterload Explanation- At shorter lengths than optimal the actin filaments overlap on themselves so reducing the number of myosin cross bridges that can be made. Afterload In vivo correlates of preload and afterload: Preload • The filling of the ventricles during diastole stretches the ventricular walls- The level of stretch is the determiner of the preload on the ventricles before blood expulsion. • Therefore preload is dependent upon the venous return to the heart. • Measures of preload relate to these previous conceptions such that end-diastolic volume, end diastolic pressure and right atrial pressure are all measures of preload Afterload • The afterload on the heart is the load against which the left ventricle ejects the blood after the opening of the aortic valve. • Diastolic arterial blood pressure is the measure of the afterload. • An increase in afterload decreases the amount of the isotonic shortening and velocity of shortening. • Hypertension increases afterload and as a result decreases the amount of isotonic shortening. Qu. 1: Which of the following structures is not involved in the movement of Ca2+ into cytosol during contraction of cardiac muscle? Describe the relationship between ventricular wall tension, chamber radius, and chamber pressure (Law of Laplace) • Stroke work- The work done by the heart to eject blood under pressure into the aorta and pulmonary artery • Stroke work= Stroke Volume x Pressure at which blood is ejected. ○ Preload and after load greatly influence SV ○ Structure greatly influence pressure • Law of Laplace- When the pressure within a cylinder is held constant, the tension on its walls increases with increasing radius. Ryanodine receptors Na-Ca exchanger L-type Ca2+ channels Sarcoplasmic reticulum √ Na+-K+ ATPase √ Mark = 2 (conf=2 ) Best Option: Na+-K+ ATPase Ca2+ moves into the cytosol of cardiac muscle via various routes, including release from the SR via ryanodine receptors, and also entry from the extracellular space via L-type Ca2+ channels and via the Na+-Ca2+ exchanger. Including wall thickness (h) T=PR/h Pasted from <https://www.ucl.ac.uk/lapt/laptlite/sys/run.htm?icl08_cvs1?f=clear?i=icl1?k=1?u=_st1511?i=Imperial> • Radius of curvature of walls of LV is less than that of RV allowing LV to generate high Stuart's Cardiovascular System Page 6 • Radius of curvature of walls of LV is less than that of RV allowing LV to generate high pressures with similar wall stress. Qu. 6: Which of the mechanisms does NOT contribute to the FrankStarling relationship (force of contraction is dependent on diastolic volume? Force depends on the number of crossbridges binding myosin to actin Force depends on the Ca2+ sensitivity of troponin C √ Force depends on the concentration of ATP around the myofilaments Force depends on the overlap between the myofilaments Force depends on the Ca2+ affinity of troponin C √ Mark = 3 (conf=3 ) Best Option: Force depends on the concentration of ATP around the myofilaments The Frank-Starling relationship is due to force being dependent upon 1) the number crossbridges that interact between the overlapping myofilaments, and 2) changes in Ca2+ sensitivity of the myofilaments, which is at least partly due to alterations to the affinity of troponin C for Ca2+. Although presence of ATP is necessary for the crossbridge cycle to occur, it is not a part of the Frank-S Pasted from <https://www.ucl.ac.uk/lapt/laptlite/sys/run.htm?icl08_cvs1?f=clear?i=icl1?k=1?u=_st1511?i=Imperial> Stuart's Cardiovascular System Page 7 • Failing hearts often become dilated increasing radius and thus decreasing pressure generation and increases wall stress. Electrical Action of the Heart 27 January 2012 14:01 Page 364 Vander's Human Physiology Learning Objectives Describe the structure of a typical cardiac ventricular myocyte. Describe the structure of a typical cardiac ventricular myocyte. Describe the main structures of the human heart. • Cardiac myocytes are about 50-100microns long. • Attach to each other as end to end junctions known as intercalated discs. • These discs have gap junctions- which allow action potential spread (syncytium) due to low resistance. Briefly describe the pathways of the heart that subserve the normal orderly passage of electrical activity through it. Sketch an intracellular action potential for a) a sino-atrial node cell b) an atrial cell c) a ventricular cell. Describe the main structures of the human heart. Conduction System • Sinoatrial node- strip of modified muscle tissue 20x4 mm in size located close to Explain why the ventricular action potential has a long duration and relate this to the function of the ventricles. State that the sino-atrial (SA) node is the normal pacemaker and explain why and how this is so. Describe how activity in the SA node spreads to both atria. where the Vena Cavae empties. • Atrioventricular node- Bridges fibrous ring of atria and ventricles which is non conducting. • Bundle of His- Bundle of rapidly conducting muscle fibres- away from AV node into the septum. • Bundle Branches- Left bundle branch runs down left side of the septum. • Purkinje Fibres- Endocardium- penetrate into ventricular muscle wall. Explain why transmission of electrical activity from the atria to the ventricles normally only occurs at the atrio-ventricular (A-V) node. • The objective of the conduction system and in particular the Purkinje fibres is that the contraction of the ventricles needs to be simultaneous in order to generate a large pressure and force the blood out. Describe how electrical activity is transmitted to all parts of the ventricles through the Bundle of His and the Purkinje fibres. • Interestingly the heart can beat outside of the body- remove and profuse it with a certain solution it will beat. Different to skeletal muscle where this wouldn't happen. Describe the ECG waveforms using the conventional PQRST nomenclature, and state the electrical events that each represents. Sketch an intracellular action potential for a) a sino-atrial node cell b) an atrial cell c) a ventricular cell. Sino Atrial Node • In depth coverage of ion channels is covered in sino-atrial node learning objective. • Sympathetic nervous system causes slope of pre-potential to increase which results in it being quicker and easy to establish an action potential and thus the heart beat will be fast. • The sympathetic nervous system uses noradrenaline. • Parasympathetic- Vagal nerve- acetylcholine Briefly describe the pathways of the heart that subserve the normal orderly passage of electrical activity through it. 1. Atrial depolarisation occurs which is initiated by the sino-atrial node. 2. Depolarisation then reaches atrioventricular node which propagates the action potential down the Bundle of His, bundle branches and finally to the purkinje fibres. 3. Purkinje fibres causes the ventricles to contract simultaneously. State that the sino-atrial (SA) node is the normal pacemaker and explain why and how this is so. • The sino-atrial node is known as the pacemaker and determines how fast the heart beats. This is because its depolarization initiates the depolarization of all other myocytes. • As opposed to typical cardiac myocytes SAN cells do not have a steady resting membrane potential and instead undergo a slow depolarization known as a pacemaker potential. Explanation of SA Nodal Cell Action Potential: + 20 mV 1. Firstly K channels close so that membrane potential will not decrease further. 2. Next Na enters via F-type channels. These are so called because they have "funny" gating behaviour as they open whilst negative. 3. Transient (T-Type) Ca channels then open to further boost towards the pacemaker potential. 4. Once this is achieved L-type Ca channels open and the action potential is propagated. Potential (mV) Threshold - 50 mV Pre-potential Time Atrial Cells • Vaguely similar in shape to SAN cells however there is no pre potential and the resting membrane potential is a lot lower at around -90mv. +20mV • The pacemaker currents within the SAN cells brings them to threshold much quicker than AVN cells which is why they act as the pacemaker. • If the AV node becomes dysfunctional then the ventricles will stop beating, this is a condition known as heart block and has a characteristic change in an ECG. • The reason why this is not fatal is because AV node cells take over pacemaker function from SAN. Although the AV beats at only 35-40 BPM it is enough to stop us from dying. • The SA node is able to depolarise about 100 times a minute however this doesn't happen due to moderate parasympathetic stimulation and the action of hormones. • Junctional fibres introduce a delay of 90ms into depolarisation which means the atria and ventricles do not contract simultaneously. Describe how activity in the SA node spreads to both atria. Potential (mV) • The action potential generated by the SA nodes spreads through the myocardium via intercalated discs and gap junctions. Explain why the ventricular action potential has a long duration and relate this to the function of the ventricles. - 100 mV 0 100 200 Time (ms) 300 400 Timing of ventricular action potential and isometric force Ventricular cells +20mV Potential (mV) Stuart's Cardiovascular System Page 8 AP scale (mV) force scale (N) +20mV Potential (mV) AP scale (mV) force scale (N) - 100 mV 0 100 200 Time (ms) 300 400 • Same resting membrane potential as atrial cells. • However the duration of the repolarization phase is much longer at 215ms in comparison to about 100ms. • This longer duration results in a plateau phase which is caused by the inwards movement of calcium ions, once the membrane potential reaches -35mv and this delays the speed with which the membrane can become more negative. AV Node cell 0 • Like ventricular but with pre potential. Explain why transmission of electrical activity from the atria to the ventricles normally only occurs at the atrio-ventricular (A-V) node. • Apart from the AV node the atria and ventricles are not electrically compatible as there is a thick layer of non conducting connective tissue between them. Thus it is entirely necessary that the action potential go through the node in order to innervate the rest of the heart myocytes. Describe the ECG waveforms using the conventional PQRST nomenclature, and state the electrical events that each represents. Potential (mV) Time in ms Typical ECG Waveform NOTE: When a wave of depolarisation is moving TOWARDS the positive electrode it causes an UPWARD deflection. When it is moving AWAY from the positive electrode it causes a DOWNWARD deflection. P wave= Atrial depolarisation QRS= Ventricular depolarisation T= Ventricular repolarisation Atrial repolarisation gets swamped by QRS Stuart's Cardiovascular System Page 9 200 Time (ms) • The long duration of the ventricular action potential is required to stop the production of a fused tetanus in myocytes. • This works as the long duration resulting in a long refractory period which means another action potential cannot be generated. • This results in a better mechanism for pumping. Describe how electrical activity is transmitted to all parts of the ventricles through the Bundle of His and the Purkinje fibres. • The Bundle of His passes down the septum and the splits into a left and right bundle branch which enter the walls of the ventricles. • These then make contact with large diameter Purkinje fibers which go on to innervate all of the cardiac myocytes. Not simultaneously but very close to, so the overall contraction is like that of squeezing toothpaste from the bottom of a tube. Understanding the ECG 27 January 2012 15:08 Learning Objectives Describe how the recordings of the six standard limb leads are obtained from the four electrodes attached to the limbs Explain briefly the principles underlying the concept of Einthoven's Triangle Describe how the recordings of the six pre-cordial (chest) leads are obtained Appreciate why the magnitude and direction of components of the ECG vary from lead to lead State how the information obtained from the chest leads is different from that derived from the limb leads Describe how the recordings of the six standard limb leads are obtained from the four electrodes attached to the limbs Attachment of electrodes • The right foot is always used as a zero volt reference point. • This leaves the two arms and the left foot for recording signals Explain briefly the principles underlying the concept of Einthoven's Triangle • Einthoven's triangle is a concept that allows us to think about the ECG in a particular way. • The heart lies in centre of an equilateral triangle formed by the two arms and the left foot which allows us to determine the relative polarities and directions of the leads. Explain why the magnitude and direction of the components of the ECG vary as the recording electrode is moved across the chest from V1 to V6 Know the normal physiological range of the mean frontal plane axis Understand what is meant by the terms left and right axis deviation, and how these conditions may occur Recordings Lead 1- This is from the Left Arm to the Right Arm. LA is the + electrode Lead 2- This is from the Right Arm to Left Foot. LF is the + electrode Lead 3- This from the Left Arm to the Left Foot. LF is the + electrode. Location of Chest Electrodes * Self Added Describe how the recordings of the six pre-cordial (chest) leads are obtained Appreciate why the magnitude and direction of components of the ECG vary from lead to lead • The effects of a wave of depolarisation are detected as the potential difference between two electrodes. • When a wave of depolarisation is moving TOWARDS the positive electrode it causes an UPWARD deflection. • When a wave of depolarisation is moving AWAY from the positive electrode it causes a DOWNWARD deflection. • • • • For aV leads the letter on the end is where the lead ends. So aVR lead ends on Right Arm. aVL lead ends on Left Arm aVF lead ends at Left Foot State how the information obtained from the chest leads is different from that derived from the limb leads 2 3 aVL aVR aVF MFPA 0 degree ++ 1 + - + - 0 MFPA 90 degree 0 + + - - ++ • In case you forget here is a few tips to remember how to know whether its positive negative etc. ○ First off determine degree of MFPA ○ If the lead you are looking at is in same direction to MFPA's big red arrow then the reading will be a ++. ○ If the lead is in the opposite direction of MFPA it will be a -. ○ If the lead is perpendicular to the MFPA then the reading will be 0. Note: • The AVR lead is almost always negative if not, you have either attached the electrodes wrong or there is some underlying pathology. Explain why the magnitude and direction of the components of the ECG vary as the recording electrode is moved across the chest from V1 to V6 • This learning objective can best be described via some trigonometry. • Think of SoH CaH ToA and the lengths of the lines as a measure of signal strength Stuart's Cardiovascular System Page 10 strength Know the normal physiological range of the mean frontal plane axis Calculations Lead II • The normal range of the MFPA is about -30 to +90 however this is affected by how the heart lies in the chest wall and upon muscle mass. • If MFPA is 60 degrees then Lead II would be exactly on the MFPA therefore the signal would be at its maximum. As the hypotenuse is the longest possible line. Lead I • However Lead I= MFPA cos a ○ I= MFPA x 0.5therefore lead 1's signal strength is half the max size. Understand what is meant by the terms left and right axis deviation, and how these conditions may occur • Left axis deviation is where the MFPA< 30 degrees. • Right axis deviation is where the MFPA>90 degrees. • Left axis deviation can be caused by malfunctioning valve and hypertrophy of left ventricle which would shift MFPA to the left. • Right axis deviation can be caused by right ventricular hypertrophy which may signal pulmonary disease. aVF • The aVF= MFPA cos b ○ MFPA cos 30 ○ aVF= MFPA x 0.87 Overall in this example: • Lead I<aVF< Lead II • Lead aVL would be 0 • Furthermore as Cos90 = 0 therefore any lead that is perpendicular to the MFPA will have a signal strength of zero. • Finally as Cos 90- 270 degrees is negative the ECG will show a downwards deflection rather than an upwards one. Location of Chest Electrodes Location of the Chest Electrodes V1- 4th intercostal space right sternal edge V2- 4th intercostal space left sternal edge V3- Directly halfway between V2 and V4 V4- 5th intercostal space mid- clavicular line V5- Anterior axillary line directly lateral to V4 V6- Mid- axillary line directly lateral to V4. qR rS Stuart's Cardiovascular System Page 11 TRANSITION ZONE Microcirculation 31 January 2012 14:04 Learning Objectives Describe the branching structure of the microvasculature. List the three types of capillary and order them in terms of their permeability to water and small lipophobic solutes Describe the branching structure of the microvasculature. List the three types of capillary and order them in terms of their permeability to water and small lipophobic solutes st order arterioles 11st Order Arterioles Describe the factors controlling capillary blood flow and explain the functional importance of capillary density Terminal arterioles Terminal arterioles Identify the different mechanisms by which solute is transported between blood and tissue (depending on size and lipid solubility). Capillary Capillary Explain how the “Starling forces” influence fluid transfer across the capillary wall Describe the origin of lymph fluid. Describe the branching structure of the lymphatic system. Understand how clinical oedema arises Pericytic-(post-capillary Post-capillary venule Pericytic venule Venule Venule Describe the factors controlling capillary blood flow and explain the functional importance of capillary density • The overall aim of the CVS is to have adequate blood flow through the capillaries so that diffusion can occur. • Blood flow rate= Volume of blood passing through a vessel per unit time. • Maximal pressure in system versus pressure as you leave the arterioles and join the capillaries. Flow = Pressure gradient/ resistance Resistance: Hindrance to blood flow due to friction between moving fluid and stationary vascular walls. Factors affecting resistance: 1. Blood viscosity 2. Vessel length 3. Vessel radius- Only one that is easily changeable R 1 r4 e.g. r halved R 16 fold Identify the different mechanisms by which solute is transported between blood and tissue (depending on size and lipid solubility). • Capillary walls act as semi-permeable membranes. Electrolytes and small lipophilic molecules cross the wall much more easy than plasma proteins. 1. Small lipid- soluble molecules such as oxygen, carbon dioxide can diffuse through the lipid bilayer. 2. Small lipid- insoluble molecules cannot easily cross plasma membranes and thus must pass through the small water filled gap junctions. There is a layer of negatively charged macromolecules (glycocalyx) which covers the endothelial cells and lines the water filled channels. These contribute to the permeability characteristics of the cell membrane. Small ions may cross this way in addition to molecules such as glucose, amino acids and drugs. 3. Large lipid-insoluble molecules are particularly affected by the type of capillary for example they find it very hard to cross continuous capillaries. However some plasma protein can leak out of the circulation and be present in the interstitial space at levels 20-70% of the blood plasma. This is important because many hormones, vitamins and lipids are transported bound to proteins. They can also cross membranes via endocytotic vesicles. Explain how the “Starling forces” influence fluid transfer across the capillary wall Fluid Movement Across Capillary: • Bulk Flow- A volume of protein free plasma filters out of the capillary, mixes with the surrounding interstitial fluid and is reabsorbed. • Hydrostatic pressure forces liquid out of the capillaries and into the tissue. • Oncotic pressure transfers liquid back into the blood vessels. This is caused by the osmotic effect of the plasma proteins within the blood. Starling's law is that there must be balance between these two forces. Stuart's Cardiovascular System Page 12 Microvessels Arterioles: • The arterioles are THE major resistance vessels. The Mean Arteriole Pressure is about 93mmHG (MAP) whereas the pressure located within the capillary bed is only about 37mmHg. • Within an organ the flow rate is determined by the MAP and the resistance within the organ itself. • Vascular Tone- Arteriolar smooth muscle normally display a state of partial constriction. • Radii of arterioles are adjusted independently to accomplish two functions: i. Match blood flow to the metabolic needs of specific tissues (depending on body's momentary needs) □ Regulated by local intrinsic controls □ Independent of nerves or hormones ii. Help regulate arterial blood pressure □ Regulated by extrinsic controls. Match blood flow to the metabolic needs of specific tissues: • Chemical- An increase in metabolism will result in an increase in oxygen usage and consumption which will cause vasodilation. This process is known as 'Active Hyperaemia'. • Physical- A decrease in blood temperature causes vasoconstriction. • Physical stretch- An increased arteriole BP causes higher level of stretching within the smooth muscle surrounding the arterioles. This will cause Myogenic Vasoconstriction which is a form of Autoregulation. The stretching causes the smooth muscle cells to open ion channels and cause muscular contraction. This significantly narrows the lumen of the arteriole so that blood pressure increases. The point of this is so that high BP can be maintained. Help regulate arterial blood pressure: • • • • • FLOW RATE= CHANGE IN PRESSURE/ RESISTANCE Resistance is dependent upon TPR or total peripheral resistance. Pressure is dependent upon Mean Arteriole Pressure Flow is Cardiac Output. Therefore: MAP= CO x TPR Relation to nervous system: • Cardiovascular control centre in the medulla. • Alpha 2 receptors in blood vessels cause vasodilation. • Beta receptors in the heart increase Cardiac Output. Relation to hormonal system: • Vasopressin and Angiotensin II are vasoconstrictors. • Adrenaline and noradrenaline are part of the sympathetic activity of the ANS. Capillaries: • Capillary exchange- The delivery of metabolic substrate to the cells of the organism. • Tiny blood vessels only 7µm in diameter. • Ideally suited to enhance diffusion via Fick's law- minimize diffusion distance and maximise surface area diffusion time. • Highly metabolically active organs usually have a more dense capillary bed. However the Pre-capillary sphincter can limit blood flow if it is not needed or it is more important for it to go elsewhere. • Lung extremely dense 3500cm2/g, skeletal muscle less so at 100cm2/g. • Between endothelial cells there are water filled gap junctions. Lipid soluble things can diffuse through membrane of endothelial cells. Hydrophilic dissolve in water. • Highly metabolically active organs usually have a more dense capillary bed. However the Pre-capillary sphincter can limit blood flow if it is not needed or it is more important for it to go elsewhere. • Lung extremely dense 3500cm2/g, skeletal muscle less so at 100cm2/g. • Between endothelial cells there are water filled gap junctions. Lipid soluble things can diffuse through membrane of endothelial cells. Hydrophilic dissolve in water. Types of Capillary: • Continuous: ○ Least permeable type of capillary and are found in skin, muscle, lungs and the nervous system. ○ They have tight junctions in between adjacent endothelial cells which only allow the passage of relatively small molecules. ○ Blood brain barrier is formed by astrocytes- this restricts access to the brain tissue by certain types of cell. • Fenestrated ○ Slightly larger gap junctions that allow bigger molecules to get through. ○ Examples are capillaries in glomerulus of the kidneys, intestinal villi and choroid plexus of the brain- CSF. ○ Fenestrae are typically 50-60nm and are covered by a very thin diaphragm derived from the Glycocalyx. • Discontinuous ○ Found in tissues such as bone marrow, liver and spleen where there is a need for red cells to enter and exit the circulation. ○ Gaps may be over 100nm which is just big enough for the 8000nm red cells to squeeze through- seemingly contortionists! • If pressure inside the capillary is greater than in the IF Ultrafiltration occurs. • If inward driving pressures are greater than outwards pressures across the capillary than Reabsorption occurs. • Usually a net loss of to the tissues which is dealt with by the Lymphatic system. Describe the origin of lymph fluid. Describe the branching structure of the lymphatic system. Understand how clinical oedema arises Structure of Lymphatic Capillaries: • Lymph capillaries are blind ended tubes that are only one endothelial cell thick. • The cells sit on an incomplete basement membrane and overlap in such a way that a valve like mechanism is caused thus only water can enter the lacteals. • The valve like mechanism is kept open by Anchoring Filaments. The functions of the lymphatic system can be summarized as follows: 1. Tissue drainage system which helps to maintain appropriate body water distribution. 2. Return of plasma proteins which have leaked out into the interstitial space back to the circulation via ducts entering the venous drainage of the arms. 3. Absorption of digested fat in the form of chylomicrons into the lacteals (lymph capillaries) of the gut. 4. Defence function at lymph nodes mediated by phagocytic cells and by lymphocytes. ○ DART- is the acronym Lymph Flow: • Within the lymphatic system there is no heart to generate pressure and thus the flow of the lymph. Instead this system is dependent upon skeletal muscular contractions within the leg and also upon the breathing mechanism. • The Right and Left Subclavian Veins are the main drainage point for the Right Lymphatic Duct and Thoracic Duct. • Approximately 3L of lymph is processed a day. Oedema: • Oedema- Excess accumulation of water in body fluid compartments. • This can be caused by 4 main factors: a. An increase in capillary blood pressure b. A decrease in plasma colloid osmotic pressure c. Blockage of the lymphatic drainage. d. An increase in capillary permeability. Stuart's Cardiovascular System Page 13 Mechanical Action of the Heart 2 31 January 2012 14:28 Learning Objectives Describe the mechanical events of the cardiac cycle State the origin of the heart sounds Describe the mechanical events of the cardiac cycle State the origin of the heart sounds Diastole- Ventricular relaxation which causes it to fill with blood. 4 sub phases Systole- Ventricular contraction 2 sub phases Use a graph to correlate electrocardiographic events and pressure events of the atria, ventricles, aorta and pulmonary artery Indicate on the graph the phases of the cardiac cycle and the corresponding pressure changes, valve openings and closures Define and state normal values for right and left ventricular end-diastolic volume, end-systolic volume, stroke volume, end-diastolic pressure and peak systolic pressure Provide the mathematical equation for ejection fraction Define cardiac output and indicate its determinants Construct simple pressure-volume diagrams from the events during the cardiac cycle and annotate these graphs appropriately Use a graph to correlate electrocardiographic events and pressure events of the atria, ventricles, aorta and pulmonary artery Indicate on the graph the phases of the cardiac cycle and the corresponding pressure changes, valve openings and closures Cardiac Cycle • The cardiac cycle can be split into 7 stages: 1) Atrial systole 2) Isovolumic contraction 3) Rapid ejection 4) Reduced ejection 5) Isovolumic relaxation 6) Rapid filling of ventricles 7) Reduced filling of ventricles • A, C and V are waves detectable in the jugular vein. • PQRST are waves commonly detected on an ECG machine. • Convention dictates that we start with atrial systole. Atrial Systole • Passive filling of ventricles is topped up by atrial contractions. • Able to feel pressure of atria in jugular vein because its near Vena Cava. • Contraction of atria causes small amount of blood to go back up Vena Cava- creates a small A wave. • P wave is atrial depolarization by the SA node. • 4th heart sound- abnormal and occurs with congestive HF, pulmonary embolism or tricuspid incompetence. Isovolumic contraction • This is the interval when all the valves are shut. Period of isometric force production to increase pressure within the ventricles. • AV valves shut when ventricular pressure exceeds atrial pressure. • QRS complex marks ventricular depolarization. • 1st heart sound- due to closure of AV valves and associated vibrations. Rapid Ejection: • Aortic and pulmonary valves open and mark this phase • Small discernible C wave in jugular vein because of RV pushing against tricuspid valve and sending more blood up vena cava. Reduced Ejection: • • • • This phase marks the end of systole. Semi-lunar valves start to close. Blood flow from ventricles decreases and ventricular volume decreases more slowly As pressures in ventricles fall below that in arteries, blood begins to flow back causing SL valves to close. • T wave is due to ventricular repolarisation Isovolumic relaxation: • • • • • The beginning of diastole. The semi-lunar valves have just shut and remain closed until the end of this phase. Atria fills with blood despite the AV valves being shut therefore pressure increases in atria. Blood pushing tricuspid valve gives second jugular pulse- V wave. Blood pushes aorta apart slightly- therefore it rebounds slightly which causes a wave- the Dichrotic notch • 2nd heart sound (dub) occurs when aortic and pulmonary valves close. Rapid ventricular filling: • Once AV valves open blood flows into ventricles. • 3rd heart sound can occur due to hypertension or mitral incompetence which causes turbulent ventricular filling. Define and state normal values for right and left ventricular end-diastolic volume, end-systolic volume, stroke volume, end-diastolic pressure and peak systolic pressure • The patterns of pressure changes in the right heart are essentially identical to those of the left. • Quantitatively the pressures in the right heart and pulmonary circulation are much lower. • Despite the lower blood pressure both sides of the heart pump the same volume of blood Reduced ventricular filling: • Sometimes known as diastasis whereby the ventricles fill much more slowly. Heart Sounds Lub= AV valves shut isovolumic contraction Dub= A+P valves shut during isovolumetric relaxation Rapid filling= mitral incompetence or hypertension Atrial systole= tricuspid incompetence, PE or CHF. Provide the mathematical equation for ejection fraction Extra Waves/ Abnormalities A- atrial systole pushing up IVC C- rapid ejection pushing back against tricuspid. V- isovolumetric relaxation Dichrotic notch- Blood pushes apart aorta so it rebounds during isovolumetric relaxation. Ejection fraction= SV/EDV Ours would be around 65% - heart failure would be about 35% Think- 'A' atrial, 'C' contraction and 'V' volumetric. 1. 2. 3. 4. End-diastolic and systolic volume • Right ventricular and left ventricular must be the same for total blood flow to be equal. • 130ml= end diastolic volume • 60ml= end systolic volume Stroke Volume Define cardiac output and indicate its determinants • End diastolic volume- End systolic volume= Stroke Volume • Approximately 70ml. Stuart's Cardiovascular System Page 14 Cardiac Output= Stroke volume x Heart Rate. Stroke Volume Define cardiac output and indicate its determinants • End diastolic volume- End systolic volume= Stroke Volume • Approximately 70ml. End-diastolic pressure • RHS- About 3-8 mmHg • LHS- About 3- 12 mmHg Peak systolic pressure Cardiac Output= Stroke volume x Heart Rate. Determinants: • Autonomic nervous system activity. • Hormones such as adrenaline. • Pathophysiology of CVS disorders. E.g. valve defects, left ventricular hypertrophy. • Preload • Afterload • Contractility • RHS- 15-30 mmHg • LHS- 100-140 mmHg Construct simple pressure-volume diagrams from the events during the cardiac cycle and annotate these graphs appropriately Define cardiac output and indicate its determinants Cardiac contractility Definition: Contractile capability (or strength of the heart) • Simple measure of cardiac contractility is ejection fraction • Contractility is increased by sympathetic stimulation • Family of different Frank-Starling relations as cardiac contractility changes Changes that occur during exercise: • During exercise contractility is increased due to increased sympathetic activity. • During exercise end diastolic volume is increased due to changes in the peripheral circulation (venoconstriction and muscle pump) • • • • Point 1 on this graph represents End Diastolic Volume of the LV. Point 2 is the aortic pressure that is encountered/isovolumic contraction Point 3 is the end-systolic volume. Point 4 is probably during isovolumic relaxation • Blood filling the ventricle during diastole determines the preload and the amount of stretch. • The blood pressures in the great vessels (aorta and pulmonary artery) represent the afterload. Remember from previous lecture that as afterload increases, the amount of shortening that occurs decreases Stuart's Cardiovascular System Page 15 ECG- Disturbances in cardiac rhythm 10 February 2012 09:11 Learning Objectives Recognize common abnormalities of cardiac rhythm on the ECG Recognize common abnormalities of cardiac rhythm on the ECG • Brachycardia○ Common symptoms include blackout, fatigue and loss of consciousness ○ Heart rate of less than 60 BPM • Tachycardia ○ Results in shortness of breath. ○ Typically has to be greater than 100 BPM • Cardiac conduction abnormalities○ AV + SA Node in sync rather than delayed slightly. • Supraventricular arrhythmias: ○ The chance of atrial fibrillation is 15% when greater than 75. ○ Atrial flutter, AVNRT present with breathlessness • Ventricular arrhythmias ○ Ventricular tachycardia, fibrillation Know the normal duration and amplitude of the components of the ECG waveform Recognize normal sinus rhythm on the ECG Describe a systematic approach to ECG interpretation Recognize a common pattern of acute myocardial infarction on the ECG Know the normal duration and amplitude of the components of the ECG waveform P wave Duration < 0.11s, Amplitude < 2.5mm in lead II PR Interval 0.12-0.20s Describe a systematic approach to ECG interpretation 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. QRS complex Duration < 0.12s Amplitude: R wave in V6 < 25mm, or R wave in V6 + S wave V1 < 35mm Axis: -30 to + 90 degrees Q wave Duration < 0.04s Amplitude: < 25% of total QRS complex amplitude QT interval 0.38-0.42s (corrected for heart rate) ST segment Should be isoelectric T wave May be inverted in III, aVR, V1 and V2 without being abnormal Is it the correct recording Identify the leads Check the calibration and speed of the paper Identify the rhythm Look at the QRS axis Look at the P wave Look at the PR interval Look at the QRS complex Determine the position of the ST segment Calculate the QT interval Look at the T wave Recognize common abnormalities of cardiac rhythm on the ECG • • • • • Sinus tachycardia Heart rate is >100BPM Rhythm is regular P waves have normal morphology Atrial rate and ventricular rate is 100-200 BPM Regular ventricular rhythm. Atrial fibrillation • A- 350-650 BPM • V: Slow to rapid (100-180) • May develop clots in their heart due to irregular rhythm and blood flow. • P wave- Fibrillatory (fine to course) • PR interval varies. • Coronary artery disease or hypertension Atrial flutter: A: 220-430BPM V: <300 BPM Rhythm regular or variable Regular ventricular rhythm. P wave- Undulating saw-toothed baseline F (flutter) waves • QRS< 0.12 s • • • • • Recognize a common pattern of acute myocardial infarction on the ECG • • • • • Deep and wide Q wave in old MI. Long QT interval predisposes people to sudden death ST elevation in infarction ST drop/ trough in angina. Hypertrophic myopathy? T wave inversion Bundle Branch Blocks • SA Node-> AV Node-> Bundle of His-> Bundle Branches-> Purkinje Fibres. • Depolarization of bundle branch and purkinje are seen as the QRS complex. Therefore a bundle branch block manifests as an alteration in the QRS complex on an ECG readout. Preexcitation syndrome: • Pathway causing early conduction between both nodes. Wolf Parkinson White Syndrome. • P wave is identical before each QRS. • QRS usually >.10. • Predisposed to arrhythmias, tachycardia etc. • Delta wave distorts QRS. Heart block: (AV Nodal Block) 1st degree- Prolonged PR interval Two ECG changes: 1. QRS Complex widens to >0.12 seconds. ○ When the conduction pathway is blocked it will take longer for the electrical signal to pass throughout the ventricles 2. QRS Morphology changes (varies depending on ECG lead, and if it is R vs. L BBB. ○ In RBBB the wide QRS complex assumes a unique, virtually diagnostic in those leads overlying the right ventricle (V1 and V2). The shape is known as Rabbit Ears. ○ May be causes by a Atrial Septal Defect. V1 Stuart's Cardiovascular System Page 16 2nd degree- Mobitz type I and II Type 1 (Wenckebach)- Gradually increasing PR interval until it drops V1 ○ In LBBB the wide QRS complex assumes a characteristic shape in these leads opposite the left ventricle (V1 and V2). The shape is a broad deep S wave. Type II- Normal PR interval then complete drop off QRS complex ○ Causes: Hypertension, aortic stenosis, dilated cardiomyopathy. Worse prognosis than RBBB- losing a lot of functionality of the myocardium 30% of efficiency is lost. Cardiac re synchronisation therapy is necessary. 3rd degree- Complete heart block ○ No correlation between PR interval and QRS complex, slow heart rate. • • • • • • Stuart's Cardiovascular System Page 17 Ventricular Tachycardia: Ventricular Fibrillation- They need CPR urgently, medical emergency. Heart rate 300-600 No regular rhythm P wave is absent No PR interval QRS- fibrillatory baseline Blood Vessels and Blood Flow 10 February 2012 10:04 Learning Objectives Understand the role and design of the normal circulation Understand the role and design of the normal circulation Be able to describe physical factors influencing flow Know ‘Ohms law for the circulation’ and the principles of the Poiseuille’s equation Understand how the compliance of the aorta and elastic arteries affect the pulse pressure Be able to describe physical factors acting on blood vessels and know the Laplace equation • To transport blood around the body (gases, nutrients, metabolites, ions, hormones, heat) • Flow is achieved by the action of a muscular pump (heart) propelling blood through a network of tubes (blood vessels). • The circulation consists of two such pumps (left and right ventricle) which are physically coupled and pump through the systemic and pulmonary circulations respectively. • Diffusion is crucial for movement of materials through tissues. • Diffusion is only effective over short distances so a capillary needs to be ~10 µm from every cell. This necessitates a highly branched structure. Large veins Large (elastic) arteries Know the basic mechanisms by which flow of blood and transmural pressure influence blood vessel structure and function Understand how standing (gravity) affects the circulation Medium sized veins Small (muscular) arteries Relative areas and volumes in the circulation Relative cross-sectional area Blood Volume (Total = 5L) Venules Arterioles Aorta Arterioles Capillaries Capillaries Pulmonary vessels ‘Exchange’ function ‘Reservoir’ function • 60-70% of total blood volume is actually in veins Know ‘Ohms law for the circulation’ and the principles of the Poiseuille’s equation Ohm's law: • MBP= CO x PVR • Mean blood volume= Cardiac output x Peripheral resistance. • Cardiac output= Stroke volume x Heart rate Poiseuille's Equation: • Relationship between pressure and laminar flow in long straight tubes. • The resistance to flow in a long straight tube depends on the viscosity of the fluid, the length of the tube and the radius of the tube. • Large elastic arteries act as conduits and dampening vessels, while muscular arteries and arterioles are important in regulating blood pressure - particularly the arterioles. Be able to describe physical factors influencing flow Blood pressure • Blood pressure is the driving force for the flow of blood around the human body and this is created by the left ventricle. • Mean Blood Pressure= Cardiac Output x Resistance • This is an approximation since flow in the circulation is not steady because of the intermittent pumping of the heart and blood vessels aren't rigid. • Pulmonary blood pressure is much lower because it has much less resistance in the vessels. Pressure throughout the circulation MBP Blood supply to organs large arteries • Where mu= fluid viscosity, L= vessel length and r = vessel radius. • This equation emphasizes the importance of arterial diameter as a determinant of resistance. • Flow is proportional to d4. Halving of the diameter will cause a 16 fold decrease in flow. small arteries • Resistance = 8µL/ πr4 left heart Heart Vena Cava Pulmonary circ Venules/veins right heart Venules and veins arterioles Capillaries veins Arterioles capillaries Aorta Pressure falls across the circulation due to viscous (frictional) pressure losses. Small arteries and arterioles present most resistance to flow. • It is important to recognise that it is the difference in pressures between the two systems that drives flow and not the absolute pressure itself. Resistance: • In the normal circulation fluid flows in laminae (layers). • In theory fluid particles in contact with the surface of the tube are stationary whilst those at the centre are flowing fastest. Viscosity, flow and shear • The dynamic viscosity is a measure of the resistance of a fluid to deform under shear stress (thickness of fluid). • The shear rate is the spatial velocity gradient at any point within the graph. • Shear stress= Shear rate x dynamic viscosity of the fluid. • Shear stress near the wall is believed to be an important influence on endothelial function in health and disease. Understand how the compliance of the aorta and elastic arteries affect the pulse pressure Stuart's Cardiovascular System Page 18 Understand how the compliance of the aorta and elastic arteries affect the pulse pressure • Kidneys 20% at rest and 4% during exercise. • Massive relative drop in GI organs. I.e. the percentage drops-however because CO is much higher the actual level of blood reaching them is still similar. Be able to describe physical factors acting on blood vessels and know the Laplace equation Know the basic mechanisms by which flow of blood and transmural pressure influence blood vessel structure and function • • • • Pulse pressure= Systolic blood pressure - diastolic blood pressure During ejection blood enters the aortal and other elastic arteries faster than it leaves them. ~40% of the stroke volume is stored by the elastic arteries. When the aortic valve closes ejection ceases but due to recoil of the elastic arteries pressure falls slowly and there is diastolic flow in the downstream circulation. • This damping effect is sometimes termed the ‘Windkessel’ • If arterial compliance decreases (arteries become stiffer), e.g. with age, the damping effect of the Windkessel is reduced and the pulse pressure increases. Compliance properties- • Transmural- Occurring across the entire wall of a blood vessel. • Laplace's equation explains the relationship between diameter, tension and pressure • See Mechanical Action of Heart • Tension = Pressure x Resistance • The relationship between the transmural pressure and the vessel volume is called the compliance and depends on vessel elasticity. • Circumferential hoop stress- (Tension/ wall thickness (h)- if high over a long period of time can cause a balloon like distension known as an aneurysm. Volume Vein Understand how standing (gravity) affects the circulation • The 120cm H20 column of blood has a pressure of 80mmHg in veins in the feet. • Gravity increases pressure in the lower limbs. • Due to the compliancy of veins they distend and blood pools here reducing venous return, preload and thus cardiac output and blood pressure. Standing causes: • Activation of baroreceptors in carotid artery and activation of sympathetic nervous system. • Release of NA which causes vasoconstriction of veins, more important is making them stiffer, not really a big change in resistance, but a big change in compliance. • In arteries diameter is reduced and Blood Pressure increases. • Myogenic venoconstriction- response to elevated venous pressure. • Contraction of skeletal muscle in leg causes blood to be pumped up from deep veins. • However cerebral blood flow does fall on standing occasionally- head rush? • Respiratory system and change in interthoracic pressure can cause contraction in veins. Negative pressure on chest expansion sucks blood into the central veins. • Valvular incompetence causes dilated superficial veins in the leg (varicose veins) • Prolong elevation of VP causes oedema in feet. Stuart's Cardiovascular System Page 19 Artery Pressure • • • • Relationship between pressure and volume is non-linear. Collagen limits distension, distension is elastin's job. Pressure 8mmHg 10 cm below heart. Veins are highly compliant at low pressures- this means that relatively small changes in venous pressure distend veins and increase the volume of blood stored in them. Endothelium 10 February 2012 14:01 Appreciate the function of the endothelium as a generator of hormones that regulate vascular and cardiac muscle form and function Appreciate the function of the endothelium as a generator of hormones that regulate vascular and cardiac muscle form and function Describe ways in which the endothelium can be stimulated and how this results in release of the named hormones: NO, prostacyclin, endothelin-1. Describe in general terms the renin-angiotensin system and know how its major components regulate vascular function Describe how the following work: low dose aspirin nitrovasodilators calcium channel blockers Appreciate why these drugs carry side effect risks along with their therapeutic benefits Endothelial cells secrete: Appreciate the function of the endothelium as a generator of hormones that regulate vascular and cardiac muscle form and function Nitric oxide: • Causes smooth muscle relaxation and inhibition of growth. • Increases blood flow to myocytes and has an effect on contractility • Also stops the aggregation of platelets. • Potent vasodilator Prostacyclin/PGI2 • Has the same effects as nitric oxide but doesn't affect contractility. • Vasodilator • Vasodilators decrease intracellular calcium levels. • • • • Nitric oxide Prostacyclin (Prostaglandin I 2) and thromboxanes Endothelin-1 Angiotensin II- converted by enzyme that is present here from a precursor Targets include: • Smooth muscle • Myocytes • Platelets Describe ways in which the endothelium can be stimulated and how this results in release of the named hormones: NO, prostacyclin, endothelin-1. Nitric oxide Thromboxane• Contraction of smooth muscle • Reduces myocyte blood flow • Stimulates aggregation of platelets • Vasoconstrictor • Sheer force stimulates nitric oxide release. Endothelin-1 • Causes contraction of smooth muscle and a weak stimulation of their growth. • Reduces blood flow to myocytes and increases contractility. • Potent vasoconstrictor/ increase blood pressure. Angiotensin II• Contraction and stimulation of growth of smooth muscle • Reduces blood flow to myocytes and is also involved in cardiac remodelling and fibrosis • Potent vasoconstrictor. ACh L-arginine analogues PLC/IP3 Ca2+ eNOS Endothelium L-arginine NO Short t1/2 sGC • Vasoconstrictors increase intracellular calcium levels. Describe in general terms the renin-angiotension system and know how its major components regulate vascular function cGMP PKG Ca2+ Short t1/2 Smooth Muscle Renin-Angiotensin System From the Liver From the Kidney On endothelial cells ACE Inhibitors ACE Inhibitors • Stimulation of ACh causes this pathway to be initiated. • Remember this parasympathetic innervation will cause vasodilation. Pathway • Endothelial nitric oxide synthase cleaves NO from L-arginine which diffuses across to smooth muscle cell. • Soluble Guanylate Cyclase releases cGMP which regulates protein kinases which lowers cellular calcium concentration. • This then decreases the ability of the muscle to contract. • NO has a very short half life. Effects • Flow induced vasodilation- fundamental to its action, response to increased sheer stress. • Vasodilation in the skin due to temperature change to help manage thermoregulation. • Penile erection mediated by increased flow dilation of the corpus cavernosum. Receptor Antagonists Stuart's Cardiovascular System Page 20 Prostacyclin/ Thromboxane • Vasodilation in the skin due to temperature change to help manage thermoregulation. • Penile erection mediated by increased flow dilation of the corpus cavernosum. Receptor Antagonists 1. Renin causes angiotensinogen to change to angiotensin I. 2. ACE is present in endothelial cells and converts angiotensin I to angiotensin II which is more biologically active. (AT-1 receptors cause vasoconstriction.) 3. ACE inactivates bradykinin which normally stimulates NOS. Prostacyclin/ Thromboxane • An enzyme called Cyclo-Oxygenase (COX) mediates the production of prostacyclin and thromboxane. • COX-1 is present in a healthy C.V.S whereas COX-2 causes inflammation and pain. • ACE inhibitors block vasoconstriction which is augmented by increasing NO release. • Angiotensin II has a number of functions which include inflammation, tissue remodeling, endothelial dysfunction and oxidative stress. • Both originate from Arachidonic acid. • Prostaglandin- IP receptor increases cAMP causes vasodilator, antiatherogenic, anti platelet. • Thromboxane- vasoconstrictor- TP receptor, Inositol Triphosphate- Opposite effects. Endothelin Describe how the following work: low dose aspirin • 21 amino acid peptide with 2 sulphide bonds. • Made in endothelial cells, endothelial converting enzyme ECE. • Endothelin can stimulate ETB receptors to cause endothelial cells to limit effect of contraction by secreting Nitric Oxide but is generally….. • An extremely potent vasoconstrictor • Upsets balance between prostacyclin and thromboxane resulting in platelets being unable to produce thromboxane. • Endothelial cells are able to synthesise prostacyclin • Platelets cannot replenish COX enzyme once aspirin is given • Low dose aspirin lowers prostacyclin and thromboxane levels. Appreciate why these drugs carry side effect risks along with their therapeutic benefits • Our body often uses the same chemical to regulate more than one process nitrovasodilators • NO donors - (nitroglycerine, nitroprusside) • eNOS activators- (endothelium dependent vasodilators) • Phosphodiesterase inhibitors- Viagra, Zaprinast • Release NO from their chemical structure • Viagra- Inhibits enzyme which would otherwise break down cyclic GMP calcium channel blockers Lipo-oxygenase leukotrienes • Dihydropyridines- Nifedipine • Phenylalkylamine- Verapamil Causes Asthma in 3-5% of patients • Blocking one of COX1 or 2 can cause build up of arachidonic acid-> lipo-oxygenase-> leukotrienes causes asthma in 3-5% of people. • Dihydropyridine calcium channel blockers are often used to reduce systemic vascular resistance and arterial pressure, but is not used to treat angina because the vasodilation and hypotension can lead to reflex tachycardia. • Bosentan- Blocks endothelin converting enzyme • Able to regulate contraction, secretion, neurotransmission, gene expression. Blocking calcium entry into the cell: • Vasodilatation reduces afterload and thus CO increases. • Negative ionotropic (decrease work done by the heart) effects occur, oxygen demand is also reduced. • They prevent coronary artery vasospasm, which makes them very useful in the treatment of variant angina. • Some drugs can be specific for membrane potential of the cells and only block these calcium channels. Stuart's Cardiovascular System Page 21 Qu. 4: Vasodilator that stimulates B1 receptors on endothelial cells to release vasodilator mediators. Best Option: bradykinin Sympathetic + Renin-Angiotensin Pathway. 10 February 2012 15:02 Learning Objectives Describe the principles of the organisation of the sympathetic nervous system Describe the synthesis, release and removal of the neurotransmitter, noradrenaline Describe the principles of the organisation of the sympathetic nervous system • The sympathetic nervous system has various effects on the cardiovascular system such as causing vasoconstriction and increasing the contractility of the heart. • There are two sympathetic trunks which lie either side of vertebral column and give off sympathetic nerves that innervate certain tissues. • The sympathetic nervous system innervates the thoracolumbar region from T1-L2. Outline the types of adrenoreceptor in the sympathetic nervous system Evaluate the cardiovascular effects of infusion of some common adrenergic agonists Describe the principles of the organisation of the renin-angiotensinaldosterone system Describe the biosynthetic pathway for angiotensin II synthesis Evaluate the individual roles the SNS and RAS play in modulating the behaviour of the CVS Recognize some of the pharmacological concepts involved in how important sympathetic neurotransmitters interact with receptors to evoke downstream effects Describe the synthesis, release and removal of the neurotransmitter, noradrenaline Outline the types of adrenoreceptor in the sympathetic nervous system From Autonomic Nervous System 1. Excitatory effects on smooth muscle ○ Alpha-adrenoreceptor-mediated 2. Relaxant effects on smooth muscle, stimulatory effects on cardiac muscle. ○ Beta-adrenoreceptor Noradrenaline Beta Receptors • B1- Cardiac muscle, smooth muscle of gastrointestinal tract • B2- Bronchial, vascular and uterine smooth muscle • B3- Found on fat cells and possibly smooth muscle of gastrointestinal tract. Alpha receptors • a1- Located post synaptically on effector cells. ○ Important in mediating constriction of resistance vessels. Small arteries and arterioles in response to sympathomimetic amines • a2- Located on presynaptic nerve terminal membrane. ○ Negative feedback loop- NA feeds back here and regulates its own release. ○ Some are actually post-synaptic on vascular smooth muscle, but not in very many vascular beds. Coupling of Alpha1-adrenoreceptors Synthesis: • Tyrosine enters the pre-synaptic neurone and is converted by Tyrosine Hydroxylase to form DOPA (dihydroxyphenylalanine). This reaction is the rate limiting step. • DOPA is converted by the enzyme DOPA carboxylase to dopamine. • Dopamine is then packaged into a vesicle within the enzyme Dopamine β hydroxylase which converts it to Noradrenaline. Release: • The granular vesicle fuses with the varicosity membrane and exocytic channels open. • The vesicle contents are expelled by exocytosis and biosynthesis and reuptake mechanisms replenish the granular contents. Coupling to Beta and Alpha 2- adrenoreceptors • Unlike with ACh there is no further metabolism of the neurotransmitter after it has been bound to its receptor. Instead a set of uptake proteins either take it back to the pre-synaptic neurone (Uptake Protein 1) or to the post-synaptic neurone (Uptake Protein 2). • Degredation of the noradrenaline is different depending upon its location: ○ In the PreSN an enzyme called Mono-amine oxidase A breaks down the noradrenaline back down to its metabolites inside the mitochondria. PreMOdona- Presynaptic= Mono-amine oxidase ○ In the PostSN an enzyme called COMT (Catechol-O-Methyl Transferase) degrades the noradrenaline. Way of remembering- "You'll catch a cold if you are broken down" Evaluate the cardiovascular effects of infusion of some common adrenergic agonists • Cardiovascular effects of catecholamines in man: 1-microgram/min infused I.V. Stuart's Cardiovascular System Page 22 Evaluate the cardiovascular effects of infusion of some common adrenergic agonists • Cardiovascular effects of catecholamines in man: 1-microgram/min infused I.V. Catecholamine Noradrenaline See T9 Signalling Two for reminder • Beta receptor are Gs receptors are therefore calcium release is mediated by adenylase cyclase- Heart causes increased contraction and rate. • A2- Inhibiting cAMP formation so lets calcium be more active in most cells. cAMP and calcium are antagonists. Adrenaline Isoprenaline Systolic BP Diastolic BP Mean BP or Heart rate Effects of catecholamines on activation of adrenoceptors Natural Describe the principles of the organisation of the renin-angiotensinaldosterone system Noradrenaline 1 2 1 Adrenaline 1 2 1 Dopamine weak effects at 1 and 1 , but has own receptors Synthetic Isoprenaline Phenylephrine 1 2 2 1 Evaluate the individual roles the SNS and RAS play in modulating the behaviour of the CVS Renin-Angiotensin System • Effects of Angiotensin II ○ Peripheral Resistance Direct vasoconstriction Enhanced action of peripheral NE □ Increased NE release □ Decrease NE uptake Increased sympathetic discharge (CNS) Release of catecholamines from adrenal • Overall rapid pressor response ○ Renal function Direct effects to increase Na+ in proximal tubule Synthesis and release of aldosterone from adrenal cortex Altered renal hemodynamics □ Renal vasoconstriction □ Enhanced NE effects in kidney • Slow pressor response ○ Cardiovascular system Haemodynamic Effects □ Increased preload and afterload Non-Haemodynamic Effects □ Increased expression of proto-oncogenes □ Increased production of growth factors □ Increased synthesis of extracellular matrix proteins • Overall causes vascular and cardiac hypertrophy and remodeling. • Low tubular Na or low BP is detected by Macula Densa cells and causes Juxtaglomerular cells to release renin which in turn eventually causes the release of angiotensin II. Describe the biosynthetic pathway for angiotensin II synthesis Recognize some of the pharmacological concepts involved in how important sympathetic neurotransmitters interact with receptors to evoke downstream effects Angiotensin II Type I (AT1) Receptors • G-protein coupled; Gi and Gq • Also couples to Phospholipase A2 • Located in blood vessels, brain, adrenal, kidney, and heart. • Activation of AT1 receptors works to increase BP. Stuart's Cardiovascular System Page 23 Aldosterone • • • • • From adrenal cortex Aldosterone maintains the body content of sodium, potassium and water. It increases sodium retention and thus water retention. It increases potassium and hydrogen ion excretion. Primary aldosteronism- caused by adenoma and you can detect this by extremely low potassium. Chymase- Generates angiotensin II but is not inhibited by ACE inhibitors. Bad effects of angiotensin II were still present. Pharmacology- Ace inhibitors interact with the kinin system- bradykinin, pain and vascular control. Stops the breakdown of bradykinin. Less ATII but more bradykinin which is a vasodilator. Angiotensin II Type I Receptor Antagonists • Actions: ○ No effects on Bradykinin system ○ Selectively blocks effects of Ang II Pressor effects Stimulation of NE system Secretion of aldosterone Effects on renal vasculature Growth-promoting effects on cardiac and vasculature tissue. STRESS SYMPATHOADRENAL- RENIN-ANGIOTENSIN SYSTEM SYSTEM BLOOD PRESSURE PLATELET ACTIVATION HEART RATE COAGULATION SODIUM/ FIBRINOLYSIS WATER RETENTION Stuart's Cardiovascular System Page 24 • Aldosterone receptors are present in the kidneys, the brain, blood vessels and the heart. Regulation of CVS 14 February 2012 14:04 Learning Objectives Describe the local mechanisms that regulate blood flow Key Equations • Stroke volume = end-diastolic volume - end systolic volume • SV = EDV - ESV Describe how blood vessel diameter and heart rate are controlled by the autonomic nervous system • Cardiac output = heart rate x stroke volume Describe how the autonomic nervous system changes the force of contraction of the heart • Mean systemic arterial pressure = cardiac output x total peripheral resistance • CO = HR x SV State the location of the baroreceptors • Mean BP = CO x TPR Define cardiac output, stroke volume and mean systemic arterial pressure and state their determinants Veins in RHS of the body can act as a blood storage mechanism- this is known as capacitance. Indicate, using simple flow diagrams, how baroreceptors control blood pressure Breathing in causes blood to return to heart more easily due to negative pressure. Describe the changes in impulse activity in the carotid sinus nerve, parasympathetic and sympathetic nerves to the heart and sympathetic vasoconstrictor nerves that take place following an increase or decrease in mean blood pressure Construct an integrated picture of the various systems that control blood pressure and be able to apply this to specific clinical examples involving blood loss or fluid overload Describe the local mechanisms that regulate blood flow Veins: Constriction determines compliance and venous return. Arterioles: Constriction determines • Blood flow to organs they serve • Mean arterial blood pressure • The pattern of distribution of blood to organs. Flow is changed primarily by changing vessel radius. Describe how blood vessel diameter and heart rate are controlled by the autonomic nervous system • Sympathetic nerve fibres innervate all vessels except capillaries and pre-capillary sphincters and some meta-arterioles • Large veins and the heart are also sympathetically innervated. • Distribution of sympathetic nerve fibers elsewhere is variable. More innervate the vessels supplying the kidneys, gut, spleen and skin and fewer innervate skeletal muscle and the brain. • NA binds to alpha-1 receptors to cause smooth muscle contraction and vasoconstriction. Vasomotor centre (VMC) in the brain • VMC is located bilaterally in the reticular substance of the medulla and the lower third of the pons. The VMC is composed of a vasoconstrictor area (pressor), a vasodilator (depressor) • The VMC transmits impulses distal through the spinal cord to almost all blood vessels. • Many higher centres of the brain such as the hypothalamus can exert powerful excitatory or inhibitory effect on the VMC. • Lateral portion of the VMC controls heart activity. F= Change in pressure/ Radius Local mechanisms regulating blood flow • Autoregulation - The intrinsic capacity to compensate for changes in perfusion pressure by changing vascular resistance. • Myogenic theory- Smooth muscle fibres respond to pressure in the vessel walls. Stretch activated ion channel (particularly calcium) may open and cause constriction. • Metabolic theory- As blood flow decreases "metabolites" accumulate and vessels dilate, when flow increases "metabolites" are washed away. e.g. CO2, H+, adenosine, K+. • Injury (serotonin release from platelets causes constriction) • Substances released from the endothelium such as Nitric Oxide which is a powerful vasodilator. • Prostacyclin and thromboxane A2 relative amounts are important for clotting. • Endothelins (powerful vasoconstrictor). Circulating hormones • Kinins- Tend to relax smooth muscle • ANP- Atrial natriuretic peptide. Secreted from the cardiac atria which is a vasodilator. Released is caused by overstretching. • VASOCONSTRICTORS: ○ ADH- Vasopressin secreted from posterior pituitary ○ Noradrenaline released from the adrenal medulla ○ Angiotensin II formed by increased renin secretion from kidney. Cardiac output = stroke volume x heart rate Cardiac output Stroke volume Describe how the autonomic nervous system changes the force of contraction of the heart Think this was a past exam question • Both autonomic fibers terminate on the sino-atrial node. • Sympathetic nerve fibers- more NA released increases gradient of pre-potential so that action potential is achieved earlier. • Binding of NA to beta 1 adrenergic increases the amount of cyclic AMP, Protein kinase A. Phosphorylation of uptake mechanism and calcium channels. More calcium floods into the cell and leaves the sarcoplasmic reticulum therefore more powerful contraction. Stuart's Cardiovascular System Page 25 Intrathoracic pressure Respiratory movements Venous return Heart rate Plasma adrenaline End-diastolic ventricular volume Atrial pressure Fight or flight response Activity of sympathetic nerves to heart Activity of parasympathetic nerves to heart Describe the changes in impulse activity in the carotid sinus nerve, parasympathetic and sympathetic nerves to the heart and sympathetic vasoconstrictor nerves that take place following an increase or decrease in mean blood pressure parasympathetic and sympathetic nerves to the heart and sympathetic vasoconstrictor nerves that take place following an increase or decrease in mean blood pressure Phosphorylation of uptake mechanism and calcium channels. More calcium floods into the cell and leaves the sarcoplasmic reticulum therefore more powerful contraction. State the location of the baroreceptors • • • • Baroreceptors are located in the carotid sinus and the aortic /arch. Aortic arch feedback via the vagus nerve. Carotid sinus via the glossopharyngeal nerve. Retard it says carotid not coronary!!! Carotid is artery is much more superior than aortic arch therefore it has to be innervated by the glossopharyngeal nerve. • Respond to pressures between 60 and 180mmHG at its most sensitive at 90-100mmHG. • Parasympathetic nervous system directly responds to the activity of the baroreceptors. • Decreased sympathetic activity via an interneurone. Indicate, using simple flow diagrams, how baroreceptors control blood pressure haemorrhage Blood volume Venous pressure Venous return to heart Atrial pressure Venous constriction Ventricular end diastolic volume Sympathetic discharge to veins Stroke volume Arterial blood pressure Baroreceptor feedback & reciprocal innervation Cardiac output reflexes Construct an integrated picture of the various systems that control blood pressure and be able to apply this to specific clinical examples involving blood loss or fluid overload Mean systemic arterial pressure = cardiac output x total peripheral resistance Arterial pressure haemorrhage Cardiac output Heart rate CO = HR x SV Stroke volume Arterial pressure Ventricular end diastolic volume Venous return Venous pressure Firing of baroreceptors Parasymp discharge to heart Reflexes Stuart's Cardiovascular System Page 26 Peripheral resistance Cardiac contractility Venous tone Symp discharge to heart Symp discharge to veins Arteriolar constriction Symp discharge to arterioles increase decrease Venous pressure Cardiovascular Stress 14 February 2012 16:02 Movement from a supine to standing position Learning Objectives Describe the cardiovascular problems associated with: movement from a supine to standing position haemorrhage exercise Explain how the components of the cardiovascular system respond to these various challenges Haemorrhage • Reduction in actual circulating blood volumes. • Decreased baroreceptor firing- attempts to increase heart contractility and heart rate, in addition to organ specific vasoconstriction. • Vertical position: a. Usual pressure resulting from cardiac contraction b. Effect of gravity on column of blood e.g. in a foot capillary, the pressure is: a. 25mmHG b. 80mmHG Giving a total of 105 mmHG • Change of posture massively increases the hydrostatic blood pressure in the veins in the legs, causing a large amount of venous distension. • Large amount of CO can be residing in the legs and not in the important places i.e. capillaries of organs. • Hydrostatic pressure drives blood out of microcirculation and into tissue cells Starling's Law • Ventricular filling during diastole determines level of stretch and stroke volume. • As a result of haemorrhage there is decreased hydrostatic pressure across the capillaries. ○ Hydrostatic pressure is higher at the arteriolar end of the capillary (the start) ○ Colloid osmotic pressure, created by plasma proteins which draws fluid back in. ○ Excess ultrafiltration is accounted for by lymphatic system. • Change of posture causes a transient hypotension this is caused by decreased ventricular filling due to pooling of blood in the veins. Compensatory mechanisms Arterial baroreceptors: • Carotid sinus • Aortic arch • Movement of fluid from tissues back into blood is known as Autotransfusion. Clearly this does not replace erythrocytes but instead substitutes the cells with liquid to maintain blood pressure. • Mass reduction in urine output as a result of stimulation of vasopressin secretion. • Angiotensin II release also helps because it is a powerful vasoconstrictor. • Aldosterone promotes sodium and water retention. • Baroreceptors send an afferent nerve to the CNS. Less baroreceptor firing causes less parasympathetic nerve action and thus greater sympathetic nerve action. Effect of decreased blood volumes • <10% 500ml results in no change in BP • 20-30% 1-1.5l decrease in BP will survive without any major intervention • 30-40% 1.5l-2l - Shock- acute circulatory failure tissues are insufficiently perfused. What to do? • Don’t cover in a blanket, the skin arterioles will dilate and you will drastically lower their blood pressure. • Increase blood pressure via fluids then once blood has been matched do a transfusion. Exercise • At rest only 10% of skeletal muscle arterioles are dilated. • Increase blood flow will cause a massive drop in TPR. • Skeletal muscle starts to be utilized, tissue starts using up more oxygen and generating more waste products. Active Hyperemia caused by oxygen usage. Control mechanisms • 'Preprogrammed pattern'- Medullary Cardiovascular Centre • Muscle chemoreceptors are also sending afferent signal to the MCC. • The MCC then has effects on sympathetic and parasympathetic neurones and therefore can affect the function of the whole cardiovascular system. TPR: • Profound sympathetically driven vasoconstriction of vascular beds is not necessary for exercise- i.e. GIT and kidney. • There is reduced sympathetic input into the skin, which stops vasoconstriction needed to dilate to dissipate the heat. • Net result is a drop in TPR but its not as great as it could be. Cardiac Output: • Increased SV and HR via increased sympathetic activity and decreased parasympathetic activity. • Starlings law- Increased venous return due to skeletal muscle pumps means that Stuart's Cardiovascular System Page 27 Increased sympathetic discharge results in: a. Increased heart rate of approximately 20 beats per minute. b. Increase in contractility c. Splanchnic/ renal vasoconstriction d. Venoconstriction Overall summary of effects of a change of posture Cardiac Output: • Increased SV and HR via increased sympathetic activity and decreased parasympathetic activity. • Starlings law- Increased venous return due to skeletal muscle pumps means that preload is increased and therefore so is the stroke volume. Negative effects: • Reduced plasma volume opposes increased venous return. ○ Decreased plasma volume results from increased capillary pressure across muscle walls ○ Loss of salt and water due to sweat. Summary • BP=CO X TPR • In summary as the increase in cardiac output is greater than the decrease in TPR then Blood Pressure will increase during exercise. Stuart's Cardiovascular System Page 28 Haemostasis and thrombosis 15 February 2012 08:57 Learning Objectives Describe in outline the normal haemostatic mechanisms including the interaction of vessel wall, platelets, clotting factors and fibrinolytic system Describe in outline the normal haemostatic mechanisms including the interaction of vessel wall, platelets, clotting factors and fibrinolytic system Functions of haemostasis 1. Prevention of blood loss from intact vessels 2. Arrest of bleeding from injured vessels Describe in outline how coagulation is regulated by the natural anticoagulant pathways Appreciate the principles of treatment of bleeding disorders and of thrombosis Describe in outline how coagulation is regulated by the natural anticoagulant pathways Fibrinolysis • Plasminogen is a substrate for tissue plasminogen activator (tPA). Normally in the blood they have low affinity for each other so new clots won't be constantly broken down. • As fibrin is formed tPA and plasminogen can both bind to it and thus a reaction occurs and plasmin is produced. • Plasmin is a proficient proteolytic enzyme and causes production of Fibrin degredation products. • Streptokinase is a bacterial activator and thus a seeming analogue of tPA that is used therapeutically for the thrombolysis of MI. Haemostatic Plug Formation 1. Vessel constriction 2. Formation of an unstable platelet plug ○ Platelet adhesion ○ Platelet aggregation 3. Stabilisation of the plug with fibrin ○ Blood coagulation 4. Dissolution of clot and repair vessel ○ Fibrinolysis XII Blood coagulation XIIa XI XIa • Once a blood vessel is damaged the first molecule that is exposed is collagen. • Platelets are either able to adhere directly to collagen or via Von Willebrand factor "grabbing" them. Platelet adhesion IXa IX INTRINSIC PATHWAY X Xa Prothrombin Coagulation proteinases highlighted in red! Va Pl Ca2+ or platelet GlpIb GlpIa collagen Release of ADP & prostaglandins Platelet aggregation GlpIIb/IIIa platelet platelet platelet Fibrinogen + Ca2+ X COMMON PATHWAY thrombin (IIa) Fibrinogen Fibrin thrombin XIIIa XIII Crosslinked fibrin 2. Indirect inhibition ○ Inhibition of thrombin generation by the protein C anticoagulant pathway Factor Vai T Factor VIIIai TM APC PS Activated Protein C + Protein S • In platelet aggregation the release of ADP and prostaglandins result in platelets being brought together (aggregated) to form the unstable plug with the being linked by Fibrinogen and Calcium. • If thromboxane is released instead then Calcium is not present and thrombin comes to aid coagulation activation. • Platelet activation is the conversion from a passive to an interactive cell. ○ Activated platelets: Change shape Change membrane composition Present new or activated proteins on their surface e.g. GpIIB/IIIa • The liver, endothelial cells and megakaryocytes are sites of synthesis of clotting factors. Blood coagulation cascade (ii) the protein C pathway down-regulates thrombin generation Thrombin Endothelial cells Von Willebrand factor EXTRINSIC PATHWAY VIIa Ca2+ VIIIa Pl Ca 2+ platelet Tissue factor (vessel damage) VIIa Ca2+ Secondary Haemostasis Platelet adhesion • We have a potent anti-coagulant system that keeps us from forming clots all over our body once all the enzymes are released in the clotting cascade. 1. Direct Inhibition ○ Antithrombin which is an inhibitor of thrombin and other clotting proteinases ○ Inhibits IXa, Xa, XIa (9,10,11) and thrombin (IIa). ○ Heparin accelerates the action of antithrombin and is found within mast cells and is used in immediate anticoagulation in venous thrombosis and pulmonary embolism. Primary Haemostasis Coagulation activation • Ultimate aim of the process is to produce thrombin so that fibrin can be produced. • Tissue factor is a receptor for clotting factor VII, enzyme-substrate complex is VIIa. • A zymogen is an enzyme that has not yet been activated which are converted to proteinases, cofactors which need to be activated at surfaces. • The surface is made of activated platelets (Pl) which localise and accelerate the reactions. • Contact activation- clotting in absence of tissue factor. Factor XII isn't extremely important for effective clotting. • Pl is a platelet membrane phospholipid. XII Blood coagulation XIIa PC T XI PC Endothelium XIa IXa IX Thrombomodulin • • • • The protein C pathway down-regulates thrombin generation. Thrombomodulin is present on normal endothelium which modulates thrombin activity. Binding to it doesn't allow it to act as a coagulant. Also has effects on Protein C which when activated breaks down Factors V and VII in combination with Protein S. • 5% of Caucasians have a modified Factor 5 called- Factor Va Leiden- this is not as easily Tissue factor (vessel damage) VIIa Protein C INTRINSIC PATHWAY EXTRINSIC PATHWAY VIIa VIIIa Pl X Xa Va Pl Prothrombin X thrombin (IIa) Stuart's Cardiovascular System Page 29 Fibrinogen Fibrin COMMON PATHWAY IXa IX INTRINSIC PATHWAY • Thrombomodulin is present on normal endothelium which modulates thrombin activity. • Binding to it doesn't allow it to act as a coagulant. • Also has effects on Protein C which when activated breaks down Factors V and VII in combination with Protein S. • 5% of Caucasians have a modified Factor 5 called- Factor Va Leiden- this is not as easily broken down so at more risk of thrombosis. X 1. 2. 3. 4. Antithrombin deficiency Protein C deficiency Protein S deficiency Factor Va Leiden Xa Va Pl Prothrombin Appreciate the principles of treatment of bleeding disorders and of thrombosis EXTRINSIC PATHWAY VIIa VIIIa Pl X COMMON PATHWAY thrombin (IIa) Fibrinogen Fibrin thrombin XIIIa XIII Crosslinked fibrin Memory tools Do everything by height as if you were drawing it. • There will be the normal side (main clotting factors) and the special side, ones that interact in special places. • Remember it is where they appear by height in the cascade. Normal side 12 11 9 10 (2) Stuart's Cardiovascular System Page 30 Special side 7 8 5 13 Haemostasis II 15 February 2012 09:19 Learning Objectives Describe what is meant by abnormal bleeding Describe what is meant by abnormal bleeding • • • • Describe patterns of abnormal bleeding with examples Describe the manifestations of venous thrombosis List the main risk factors for venous thrombosis 'Spontaneously' can be into joints or muscle Out of proportion to the trauma/injury Unduly prolonged Restarts after appearing to stop 12% of the population have 'easy bruising' Give a rough estimate of its prevalence Be acquainted with the principles of treatment of venous thrombosis Describe patterns of abnormal bleeding with examples • Epistaxis- nose bleed not stopped after 10 mins compression • Cutaneous haemorrhage or bruising without apparent trauma • Menorrhagia requiring treatment or leading to anaemia, not due to structural lesion of the uterus. • Prolonged bleeding from trivial wounds, or in oral cavity or recurring spontaneously in 7 days after wound. Spontaneous GI bleeding leading to anaemia. Describe patterns of abnormal bleeding with examples Primary Haemostasis Deficiency Common Examples Collagen-vessel wall Steroid therapy, age and interestingly scurvy. YYYARGGHHH Describe patterns of abnormal bleeding with examples Von Willebrand factor Von Willebrand disease (genetic) Platelets Aspirin and other drugs. Thrombocytopenia (low platelets) Secondary Haemostasis- Fibrin Mesh Formation Deficiency or defect of Coagulation Factors (I-XIII) Haemophilia: FVIII or FIX due to genetic defect. Liver disease (acquired- most coagulation factors are made in the liver) Drugs (warfarin-inhibits synthesis of Coagulation factors) Dilution- given crystalloids. Giving red blood cells without plasma dilutes coagulation factors and inhibits clotting. • Consumption (DIC- Disseminated intravascular coagulation) • • • • • Pattern of bleeding with defect in primary haemostasis • Immediate • Menorrhagia • Bleeding after trauma/surgery • Easy bruising • Petechiae- typical of thrombocytopenia. Looks like a thousand pin pricks on the legs. Platelets are constantly busy blocking small holes in blood vessels so once platelets drop we can bleed through them. • Nose bleeds (>20mins) • Gum bleeding Excess Fibrinolysis Causes Examples Excess fibrinolytics (plasmin, tPA) Therapeutic administration Some tumours Deficient antifibrinolytic (antiplasmin) Antiplasmin deficiency (genetic) Disseminated intravascular coagulation: • Generalised activation of coagulation by tissue factor. • Association with sepsis, major tissue damage + inflammation. • Powerful inflammatory response causes monocytes to express Tissue Factor which shouldn't happen. Tissue factor should be external to the circulation, the expression of it inside the bloodstream causes mass coagulation. • Consumes and depletes coagulation factors and platelets. • Activation of fibrinolysis depletes fibrinogen. Consequences • Widespread bleeding from IV lines, bruising and internal. • Deposition of fibrin in vessels causes organ failure, • • • • • • Thrombosis • Artery- Myocardial infarction, stroke, limb ischaemia. • Vein- Pain and swelling ○ These both result from an obstructed flow of blood. • Can cause an embolism. • Venous emboli to lungs (pulmonary embolus) • Arterial emboli usually from the heart, may cause stroke or limb ischaemia. Typically with atrial fibrillation. Patterns of bleeding in secondary haemostasis: Often delayed Deeper joints and muscles Not from small cuts etc. Nosebleeds rare Bleeding after trauma/surgery After intramuscular injections Describe the manifestations of venous thrombosis • After a pulmonary embolism one can have: List the main risk factors for venous thrombosis Death VT mortality 5% Recurrence 20% in first 2 years and 4% pa thereafter Thrombophlebitic syndrome Severe TPS in 23% at 2 years (11% with stockings) Thrombosis is Multi-Causal Arising from Interacting Genetic and Acquired Risk Factors Pulmonary hypertension 4% at 2 years Give a rough estimate of its prevalence Risk Acquired risk Cumulative risk Thrombotic threshold Risk from “ageing” Genetic risk 2 Genetic risk 1 Age • • • • Overall 1 in 1000. Incidence doubles with each decade. PE is cause of 10% of hospital deaths. Estimated 25k preventable deaths per annum List the main risk factors for venous thrombosis Increased risk of thrombosis- "thrombophilia" • Clinical: • Thrombosis at young age • ‘idiopathic thrombosis’ • Multiple thromboses • Thrombosis whilst anticoagulated • Laboratory • Identifiable cause of increased risk ○ AT deficiency, Factor V Leiden, global measures of coagulation activity. Virchow's triad Acquired risks for thrombosis: • Numerous conditions will alter blood coagulation, vessel wall and/or flow to precipitate Blood Stuart's Cardiovascular System Page 31 Genetic risk 1 Age • Identifiable cause of increased risk ○ AT deficiency, Factor V Leiden, global measures of coagulation activity. Virchow's triad Blood • Deficiency of anticoagulant proteins ○ Antithrombin ○ Protein C ○ Protein S • Excess of coagulation factors ○ Factor V Leiden- increased activity due to protein C resistance ○ Factor VIII ○ Factor II and others ○ Thrombocytosis (increased platelets) Vessel wall • Many proteins active in coagulation are expressed on the surface of endothelial cells and their expression is altered in inflammation. ○ Thrombomodulin ○ Tissue factor ○ Tissue factor pathway Flow • Stasis increases the risk of venous thrombosis ○ Surgery ○ Fracture ○ Long haul flight ○ Bed Rest Stuart's Cardiovascular System Page 32 Acquired risks for thrombosis: • Numerous conditions will alter blood coagulation, vessel wall and/or flow to precipitate thrombosis or make it more likely. • Oral contraceptive pill • Pregnancy • Surgery • Inflammatory response • Malignancy ○ OPSIM Be acquainted with the principles of treatment of venous thrombosis • Treatment: to lyse clot • e.g. tPA (high risk of bleeding) • Treatment: to limit recurrence/extension • Increase anticoagulant activity ○ e.g. heparin (immediate acting, parenteral) • Lower procoagulant factors ○ e.g. warfarin (oral, slow acting for long term therapy) • Prevention (NICE Guidelines 2010) • Assess individual risk and circumstantial risk • All patients admitted should have VTE risk assessment • Give prophylactic antithrombotic therapy ○ (eg heparin for in-patients) ○ +/ TED stockings Atherosclerosis I 24 September 2012 21:46 Learning Objectives The pathology and natural time-course of atherosclerosis, including the meaning of commonly used pathological terms. The connection between cholesterol and the development of atherosclerosis. The contributions that vascular endothelial cells, macrophages and vascular smooth muscle cells make to the development of lesions. The pathology and natural time-course of atherosclerosis, including the meaning of commonly used pathological terms. • Atherosclerosis is one of the most common diseases in the UK and is responsible for the majority of deaths from cardiovascular disease. • Atherosclerosis is a disease of medium and large arteries. Although the clinical manifestations usually do not appear until middle-old age, the disease has a long “lead in”, with changes in arteries occurring from early life. There is therefore plenty of time for prevention. The association between atherosclerosis and non-laminar blood flow at arterial branch-points and -curvatures. The reasons for atherosclerotic plaque instability leading to acute clinical events. The link between the pathology of atherosclerosis and clinical symptoms. The connection between cholesterol and the development of atherosclerosis. • The disease starts as a thickening on one side of the artery. This develops into an atherosclerotic “plaque”, consisting of a necrotic core of dead tissue covered and separated from the blood by a fibrous cap. • Probably the first event in the development of atherosclerosis is trapping within the arterial wall of low density lipoproteins (LDL) rich in cholesterol. This occurs through the binding of LDL to proteoglycans in the arterial intima, such as biglycan and versican. The contributions that vascular endothelial cells, macrophages and vascular smooth muscle cells make to the development of lesions. • Once trapped in the arterial wall, LDL becomes chemically denatured by reactive oxygen free radicals and/or by tissue enzymes (such as phospholipases). This results the phagocytosis of LDL by macrophages, via scavenger receptors such as Scavenger Receptor A and CD36. Macrophages that have taken up an excess of lipid are known as “foam cells”. • Release of inflammatory mediators by macrophages and other cells results in the activation of vascular endothelial cells with expression of adhesion molecules and chemo-attractants for monocytes (such as cytokines, chemokines and ox-phospholipids), recruitment of more monocytes from the blood and their differentiation within the arterial wall into macrophages. Hence the process is self-perpetuating. • As part of the inflammatory process activated macrophages (foam cells) can release: 1. Free radicals 2. Proteases 3. VSMC growth factors 4. Angiogenic factors 5. Apoptosis Summary Main cellular players: • Vascular Endothelial Cells ○ Barrier function ○ Leukocyte recruitment • Platelets ○ Thrombus generation ○ Cytokine and growth factor release • Monocyte-macrophages ○ Foam cell formation ○ Cytokine and growth factor release ○ Major source of free radicals ○ Metalloproteinases • Vascular smooth muscle cells ○ Migration and proliferation ○ Collagen synthesis ○ Remodelling and fibrous cap formation • T lymphocytes Stuart's Cardiovascular System Page 33 The association between atherosclerosis and non-laminar blood flow at arterial branch-points and -curvatures. • The distribution of atherosclerotic lesions is not random, with branch points and curvatures being “hot spots”. This is probably because of the non-laminar blood flow at these sites. There is evidence that laminar blood flow suppresses inflammatory activation of endothelial cells, whereas non-uniform blood flow at hot spots may enhance it. • High velocity lamina flow in common carotid creates sheer force that protects against it. • Complex flow and oscillations sets up inflammatory gene expression in endothelial cells. • As the plaque grows it is invaded by small blood vessels that develop from the vasa vasorum in the adventitia. These vessels tend to bleed, and thereby contribute to the growth of the necrotic core through the supply of erythrocyte-derived cell membranes. • The stability of an atherosclerotic plaque is related to the strength of the fibrous cap separating the blood from the necrotic core. The fibrous cap consists largely of collagens synthesized by vascular smooth muscle cells. The reasons for atherosclerotic plaque instability leading to acute clinical events. • Plaque erosion- Breakdown of endothelial lining of the lesion without full rupture of the fibrous cap. • Plaque rupture- Breakdown of the fibrous cap of tissue separating the plaque from the blood. • Rupture of the plaque is probably usually caused by the activity of proteases expressed by macrophages fragmenting the matrix of the fibrous cap, but can also be caused by intraplaque haemorrhage (see above). ○ Metalloproteinases • Vascular smooth muscle cells ○ Migration and proliferation ○ Collagen synthesis ○ Remodelling and fibrous cap formation • T lymphocytes ○ Macrophage activation The link between the pathology of atherosclerosis and clinical symptoms. • Chronic symptom (eg angina, intermittent claudication) are attributable to limitation of blood flow through atherosclerotic narrowing (stenosis) of the arterial lumen. Factors predisposing to instability: 1. 2. 3. 4. 5. Large soft eccentric lipid-rich core Thin fibrous plaque Low collagen content Infiltrate of activates mo-mos and T cells Neovascularization Acute Events • The Glagov Phenomenon- describes the early expansion of blood vessels to account for plaque • When the vessel has intermediate or advanced lesions this is window of opportunity for primary prevention i.e. adjustment of the person's life style and reducing exposure to risk factors e.g. stopping smoking, reducing cholesterol etc. • As soon as complications such as stenosis appear, it is the time for clinical intervention. This is known as secondary prevention and may include catheter based interventions or revascularisation surgery. If the patient's condition is particularly bad then treatment for heart failure may be needed. • Occlusive Thrombus • Blood coagulation at the site of rupture may lead to an occlusive thrombus and cessation of blood flow • Embolism • Dislodgement of solid material (e.g. platelet plug, thrombus, cholesterol-rich plaque contents) into the arterial circulation leading to occlusion at distant sites. • The consequences depend on the size of the embolus and the target (e.g. brain, eye, bowel, limbs) ○ This links into the video that we saw. Effects of arterial occlusion from thrombosis or embolism • Transient occlusion- Short ischaemia from an occlusion spontaneously resolves • e.g. in brain "Transient Ischaemic attack" • e.g. in eye "amaurosis fugax" • Infarction is the death of tissue due to unresolved ischaemia • e.g. in heart Myocardial Infarction • e.g. in brain Cerebrovascular accident (CVA or stroke) Vasa Vasorum gives a back door for leukocyte recruitment: • As the plaque grows it becomes ischaemic so that blood doesn't get into the centre of the plaque. • This stimulates VCAM-1 that stimulates more vessel growth which are weak and can easily rupture. Stuart's Cardiovascular System Page 34 Atherosclerosis + Endothelium 21 February 2012 15:00 Learning Objectives The basic functions of endothelial cells The importance of vascular endothelium for the health of blood vessels The importance of vascular endothelium in Cardiovascular diseases, including atherosclerosis How the endothelium regulates leukocyte recruitment and inflammation How the endothelium drives the formation of new vessels (angiogenesis) The importance of angiogenesis in cardiovascular diseases Important Characteristics of Vascular Endothelium The basic functions of endothelial cells • Extremely large number of factors that they help regulate including angiogenesis, vascular tone and permeability. • Surface area greater than 1000m2 • Acts as a vital barrier separating blood from tissues. • Formed by a monolayer of endothelial cells, one cell deep (contact inhibition) ○ Due to changing blood pressures cells need to be able to adapt and potentially move. • Endothelial cells are very flat, about 1-2 microns thick and 10-20 microns in diameter. • Heterogeneity of cells. • In vivo, endothelial cells live a very long life and have a low proliferation rate (unless angiogenesis is required) • The contact between 2 cells is regulated by many proteins and regulated as if it was a zipper. Contact inhibition- essential survival mechanisms. The importance of vascular endothelium in Cardiovascular diseases, including atherosclerosis • There is an important balance between protective and potentially damaging actions of the vascular endothelium. Protective • Anti-inflammatory • Anti-thrombotic • Anti-proliferative How the endothelium regulates leukocyte recruitment and inflammation • Integrins get activated and bind to the vascular endothelium and interact with molecules such as Selectins, Icams and Becams. Deleterious • Pro-inflammatory • Pro-thrombotic • Pro-angiogenic • The problem of atherosclerosis is that you have a number of activators: a. Mechanical stress b. Viruses c. Smoking d. Inflammation e. High Blood Pressure f. High Glucose • This then results in the balance being shifted to the pro-inflammatory side which makes atherosclerosis worse. How the endothelium drives the formation of new vessels (angiogenesis) • Angiogenesis- Formation of new blood vessels by sprouting from pre-existing blood vessels • Leukocytes also engage with molecules such as ICAM and PECAM which allows them to pass through the junctions between cells to enter the tissue. Venules vs. arteries • Tumours are vary good at producing angiogenic factor. The importance of angiogenesis in cardiovascular diseases Angiogenesis and cardiovascular disease Stuart's Cardiovascular System Page 35 The importance of angiogenesis in cardiovascular diseases Angiogenesis and cardiovascular disease • Angiogenesis promotes plaque growth • Therapeutic angiogenesis prevents damage in post-ischaemic tissue. Introduction of growth factors/ stem cells may allow a new blood vessel to form and thus be a natural bypass mechanism. • Capillary: endothelial cells surrounded by • Artery: Three thick layers, rich basement membrane and pericapillary cells in cells and extracellular matrix (pericytes) • Post-capillary venule: Structure similar to capillaries but more pericytes • • Leukocytes cannot pass all the way through the blood vessels and gets stuck in the sub- endothelial space. Endothelial dysfunction in atherosclerosis Leukocytes Recruitment • Recruitment of leukocytes into tissues takes place normally during inflammation: leukocytes adhere to the endothelium of post-capillary venules and transmigrate into tissues. • In atherosclerosis, leukocytes adhere to activated endothelium of large arteries and get stuck in the subendothelial space. • Newly formed post-capillary venules at the base of developing lesions provide a further portal for leukocyte entry. Endothelial dysfunction in atherosclerosis Cellular Senescence • Replication senescence: the limited proliferative capacity of human cells in culture • Senescence as response to stress and damage: locks cells in a permanent form of growth arrest. • Linked to progressive shortening and dysfunction of telomeres (ends of chromosomes) • Senescent cells have distinctive morphology and acquire specific markers, e.g. Beta gal. • Senescence cells are pro atherosclerotic and therefore not good news. • Endothelial cell senescence can be induced by CV risk factors, such as oxidative stress, that promote increased cell replication to replace dead or damaged cells. • These changes result in pro-inflammatory, pro-atherosclerotic and prothrombotic phenotype. The French Paradox • Huge difference in male death rates in CAD in England compared to France. • Resveratrol promotes endothelial protective pathways. • Resveratrol acts as an anti-ageing compound and reduces vascular cell senescence. Vascular permeability • The endothelium regulates the flux of fluids and molecules from blood to tissues and vice versa. • Increased permeability results in leakage of plasma proteins through the junctions into subendothelial space. • In atherosclerosis there are a number of factors that contribute to occluding the vessel. The include: a. Smooth muscle migration b. Foam-cell formation c. T-cell activation d. Adherence and aggregation of platelets e. Adherence and entry of leukocytes. Stuart's Cardiovascular System Page 36 Endothelial Progenitor Cells • Circulating bone marrow derived CD34+ stem cells, of haematopoietic lineage which can differentiate into mature endothelial cells. • EPC mobilisation from the BM may be triggered by ischaemia, pro-angiogenic growth factors, statins. • Circulating EPC migrate and home to sites of ischaemia and contribute to re endotheliazation and angiogenesis Pathophysiology of Heart Failure 24 February 2012 14:00 Learning Objectives Epidemiology of heart failure Heart Failure-Syndrome which arises when the heart is unable to maintain an appropriate blood pressure without support. Epidemiology of heart failure Signs and symptoms of heart failure • A clinical syndrome caused by an abnormality of the heart with characteristic pattern of haemodynamic, renal, neural and hormonal responses. Assess the severity of symptoms Epidemiology of heart failure Determine the aetiology of heart failure Identify the concomitant diseases relevant to heart failure Anticipate complications Choose appropriate treatment • • • • • • Prevalence- 1-3% in the population- 10% in those aged over 75. Incidence= 0.5-1.5% per annum Prognosis worse than cancer 50% dead in 3 years. In community the mean age is 76 years old. Men:Women is 50:50 5% of acute hospital admissions and 10% bed occupancy 40% of admissions dead in one year. Signs and symptoms of heart failure Monitor progress and tailor treatment Assess the severity of symptoms NYHA classification of functional capacity Class I- Patients with cardiac disease but without resulting limitation of physical activity. Ordinary physical activity does not cause undue fatigue, palpitation, dyspnea, or anginal pain. Class II- Patients with cardiac disease resulting in slight limitation of physical activity. They are comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea, or anginal pain. Class III - Patients with cardiac disease resulting in marked limitation of physical activity. They are comfortable at rest. Less than ordinary activity causes fatigue, palpitation, dyspnea, or anginal pain. Class IV - Patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms of heart failure or the anginal syndrome any be present even at rest. If any physical activity is undertaken, discomfort is increased. Progression of heart failure Loss of myocardium Fall of BP - baroreceptors ergoreflexes & chemoreflexes activated Maintains hormone activation Onset of heart failure Quality of life The Nature of Heart Failure: Bacterial invasion Immune & inflammatory response Onset of cachexia Hastens demise Progression Sudden death Coronary events • • • • • • Patient is breathless, tired and retains fluid Heart is damaged Heart less effective as a pump Marked neurohormonal activation Quality of life is poor Life expectancy reduced Mild Moderate Severe Time Signs: 1. Pitting oedema- Pressing on the limb causes the skin to pit and remain so for a time being. 2. Increased jugular venous pressure 3. Ascites 4. Dilated heart Death Syndromes of Heart Failure • Acute heart failure= Pulmonary oedema • Circulatory collapse- Cardiogenic "shock" (poor peripheral perfusion, oliguria, hypotension) • Chronic heart failure- Untreated, congestive undulating, treated, compensated Determine the aetiology of heart failure 1. Arrhythmias 2. Valve disease- mitric regurgitation 3. Pericardial disease- pericardium is too tight so heart cannot expand and contract effectively. TB- pericardial infection and fibrosis 4. Congenital heart disease- Fallous tetphalgy 5. Myocardial disease- death of heart muscle ○ Coronary artery disease ○ Cardiomyopathy- Dilated (DCM)- specific or idiopathic (IDCM). Hypertrophic (HCM or HOCM or ASH). Restrictive. Arrhythmic right ventricular cardiomyopathy (ARVC) ○ Hypertension ○ Drugs: Beta blockers Calcium antagonists Anti-arrhythmics ○ Other or unknown Dilated heart - no fluid retention in lungs Trachea Superior vena cava Bronchial bifurcation Anterior rib Vascular hilum Spinal process Clavicle Scapula Aortic arch Left bronchus Pulmonary artery Left atrial appendage Posterior rib Heart disease and heart failure Stuart's Cardiovascular System Page 37 Descending aorta Right atrium Diaphragm Breast soft tissue Superior vena cava Scapula Aortic arch Bronchial bifurcation Anterior rib Calcium antagonists Anti-arrhythmics ○ Other or unknown Left bronchus Pulmonary artery Left atrial appendage Vascular hilum Posterior rib Descending aorta Heart disease and heart failure • Coronary heart disease is the leading cause of death in Europe ○ Left anterior descending coronary artery termed the widow maker. ○ Echocardiogram very common and well used to diagnose cardiac failure. Ventricular wall should be 4.5 cm in diameter. • Modern treatment increases survival • Survivors are left with a damaged heart • 50% of all survivors develop heart failure • Deaths due to heart attacks are declining but due to heart failure are increasing • the population is ageing and heart failure is commoner in old age • Only a minority of patients with heart failure are receiving the latest drugs. Right atrium Breast soft tissue Diaphragm Liver Gastric air bubble Anticipate complications Causes of death in heart failure Identify the concomitant diseases relevant to heart failure Cardiomyopathy and chronic heart failure • Cardiomyopathy is heart disease in the absence of a known cause and particularly coronary artery disease, valve disease and hypertension. • Cause of approximately 5% of heart failure in a population ○ ○ ○ ○ Hypertrophic cardiomyopathy Dilated cardiomyopathy Restrictive cardiomyopathy Arrhythmic right ventricular cardiomyopathy 1:500 1:5,000 1:10,000 1:5,000 1. Progression of heart failure ○ Increased myocardial wall stress ○ Increased retention of sodium and water 2. Sudden death ○ Opportunistic arrhythmia ○ Acute coronary event (often undiagnosed) 3. Cardiac event e.g. MI 4. Other cardiovascular event e.g. stroke, PVD 5. Non cardiovascular cause ○ PSCON Hormonal mediators in heart failure ○ Mutation in Titan gene accounts for about a quarter of cardiomyopathy. Causes of dilated cardiomyopathy 1. 2. 3. 4. 5. 6. Infectious causes: Viruses and HIV Rickettsia Bacteria Mycobacteria Fungus Parasites Dilators Growth Factors Noradrenaline ANP Insulin Renin/angiotensin II Prostaglandin E2 and metabolites TNF alpha Toxins and poisons 1. 2. 3. 4. Constrictors Ethanol Cocaine Metals Carbon dioxide or hypoxia Endothelin EDRF Somatostatin Vasopressin Dopamine Angiotensin II NPY CGRP Catecholamine NO Cytokines and oxygen radicals Inflammatory markers and cytokines Drugs- Chemotherapeutic agents, antiviral agents Metabolic disorders- Nutritional deficiencies and endocrine disease Collagen disorders, autoimmune cardiomyopathies, peri-partum cardiomyopathy, neuromuscular disorders. Inflammatory markers and cytokines Causes of restrictive cardiomyopathy Associated with fibrosis- Diastolic dysfunction: Elderly, hypertrophy, ischaemia, scleroderma Infiltrative disorders- Amyloidosis, sarcoid disease, inborn errors of metabolism, neoplasia Storage disorders- Haemochromatosis and haemosiderosis. Fabry disease, glycogen storage disease Endomyocardial disorders- Endomyocardial fibrosis, hypereosinophilic syndrome carcinoid, metastases, radiation damage. Organ specific: All cell types: Heart Troponin T Troponin I Interleukin-1b Interleukin-6 Tissue necrosis factor Vessel wall ICAM-1 VCAM-1 E-selectin P-selectin Macrophages Choose appropriate treatment Objectives of treatment in chronic heart failure 1. Prevention ○ Myocardial damage Occurrence Progression of damage Further damaging episodes ○ Reoccurrence Symptoms Fluid accumulation Hospitalisation 2. Relief of symptoms and signs ○ Eliminate oedema and fluid retention ○ Increase exercise capacity ○ Reduce fatigue and breathlessness 3. Prognosis ○ Reduce mortality Options in the treatment of heart failure Lipoprotein-associated phospholipase A2 Secretory phospholipase A2 Adipose tissue Liver C-reactive protein Fibrinogen Serum amyloid A Monitor progress and tailor treatment Management algorithm for heart failure 1. 2. 3. 4. 5. 6. 7. 8. Establish that patient has heart failure Determine aetiology of heart failure- do BNB send for an echo cardiogram Identify concomitant disease relevant to heart failure- coronary artery disease Asses severity of symptoms Predict prognosis Anticipate complications- clots, arrhythmias, Choose appropriate treatment- beta blockers, ACE inhibitors + physical devices. Monitor progress and tailor treatment- impella pump? Heart failure Choose appropriate treatment K+ sparing, 1. Drugs Diuretics, Loop, thiazide, metolazone, spironolactone or combination ACE inhibitors, Beta-blockers, Digoxin, Aspirin, statins, anticoagulants, Angiotensin II receptor inhibitors, nitrates, hydralazine, antiarrhythmics, IV inotropes 2. Surgery, CABG or valve surgery 3. Implantable cardioverter-defibrillator - ICD, pacing 4. Haemofiltration, peritoneal dialysis or haemodialysis 5. Aortic balloon pump, ventricular assist devices cardiomyoplasty, volume reduction, transplantation Stuart's Cardiovascular System Page 38 Severe heart failure- possible treatments Intravenous drugs○ Diuretics or combination of diuretics ○ Nitrates ○ Positive inotropes - dopamine/dobutamine Fluid control ○ Haemofiltration ○ Peritoneal dialysis or haemodialysis Devices ○ ICD or pacing ○ Intraaortic balloon pump Ventricular assist device, total artificial heart ○ Ventricular assist device, total artificial heart Surgery ○ ○ ○ ○ Stuart's Cardiovascular System Page 39 CABG for "hibernation" Valve surgery Cardiomyoplasty, volume reduction/restriction Transplantation Hypertension 24 February 2012 15:00 SLIDES ARE ANNOTATED!!! Summary • BP levels are continuously distributed in a population Parameters of hypertension • The definition of hypertension is arbitrary and is based on the balance of the risks of elevated BP versus the risks of investigation and treatment • 90-95% of cases of hypertension have no identifiable cause (primary or essential hypertension). • Secondary hypertension is rare, but important causes include renal disease, tumours secreting aldosterone (Conn’s syndrome), and tumours secreting catecholamines (pheochromocytoma) • RAT- Renal, Aldosterone, Tumour secreting catecholamines. • Established hypertension is due to elevated peripheral vascular resistance • The increased peripheral resistance in hypertension is due to active vasoconstriction and structural narrowing of small arteries and loss of capillaries (rarefaction) % of screened population • Increased BP is associated with increased risk of cardiovascular disease – (strokes, myocardial infarction (heart attacks), heart failure and atheromatous disease) 20 15 Australia (1979) Veterans Admin (1967,’70) Hamilton (1964) 10 • Hypertension is associated with left ventricular hypertrophy, increased wall thickness in large arteries, remodelling in smaller arteries and rarefaction of the microvasculature • The cause of primary hypertension is unknown but the strongest evidence implicates renal abnormalities and/or excessive activity of the sympathetic nervous system MRC (1985) Australia (1980,’81) 5 0 50 60 70 80 90 100 110 120 130 Diastolic BP (mmHg) BP distribution is unimodal and any distinction between normal and abnormal is arbitrary. Hypertension can be defined as the level of blood pressure above which investigation and treatment do more good than harm. Age and hypertension • Almost half of the people who suffer the disability and life years lost are below the hypertensive cut off point. • Need to target both hypertensive individuals and target people as a population to reduce to the left of cut off point. Causes of hypertension Identifiable causes – secondary <5% e.g. • Renal disease, including renal artery stenosis, • Tumours secreting aldosterone (Conn’s syndrome) • Tumours secreting catecholamines (pheochromocytoma) • Oral contraceptive pill • Pre-eclampsia/pregnancy associated hypertension • Rare genetic causes (e.g. Liddle’s syndrome) Genes and environment in aetiology of primary hypertension Genetics: • Monogenic (rare) • Complex polygenic (common) <1mmHG effect. • • • • • • Environment: Dietary salt intake Obesity/ overweight, lack of exercise Alcohol Pre-natal environment (~birthweight) Pregnancy (pre-eclampsia) Other dietary factors and environmental exposures. Unidentifiable cause – primary or essential (90-95% of cases) Haemodynamics of hypertension • Estimates suggest that the heritability of high blood pressure is around 30-50%. Classical single gene (monogenic) causes of hypertension are very rare, and it is believed that numerous genes each contributing only a small effect explain the heritable component of high BP. Genes and blood pressure • Twin and other studies suggest 30-50% of variation in blood pressure is attributable to genetic variation. ○ Liddle's syndrome- Mutation in amiloride-sensitive tubular epithelial Na channel ○ Apparent mineralocorticoid excess- Mutation in 11 beta-hydroxysteroid dehydrogenase • Complex polygenic causes ○ Multiple genes with small effects (positive and negative) ○ Interactions with sex, other genes, environment Major risks attributable to elevated blood pressure • Increased risk of ○ Coronary heart disease ○ Stroke ○ Peripheral vascular disease/atheromatous disease Hypertension is commonly associated with thickened walls of large arteries and acceleration of atherosclerosis. Hypertension may cause arterial rupture or aneurysms. This can lead to thrombosis and haemorrhage which in turn can cause strokes. ○ Heart failure Atrial fibrillation Stuart's Cardiovascular System Page 40 BP= CO x TPR 1. 2. 3. 4. 5. Increased total peripheral resistance Reduced arterial compliance (higher pulse pressure) Normal cardiac output Normal blood volume/extracellular volume Central shift in blood volume ○ Secondary to reduced venous compliance Causes of elevated PVR in hypertension • Excessive active narrowing of arteries- most likely short term vasoconstriction • Structural narrowing of arteries- growth and adaptive remodelling process • Loss of capillaries- Rarefaction. Candidates causes of primary hypertension • Kidney ○ Key role in BP regulation (guyton) ○ Best evidence especially in relation to salt intake • Sympathetic nervous system ○ Evidence linking high sympathetic activity to the development of hypertension • Endocrine/paracrine factor ○ INCONSISTENT EVIDENCE ○ Atrial fibrillation ○ Dementia/cognitive impairment ○ Retinopathy: Normal Kidney as a cause of hypertension Hypertensive Grade III retinopathy Silver wiring (wall thickening) Haemorrhages (wall rupture) AV nipping (wall thickening) Hard exudates (plasma leaks) • The kidney exerts a major influence on BP – Guton’s concept of ‘infinite gain’ of renal sodium/water/BP regulation • Impaired renal function or blood flow is the commonest 2º cause of hypertension (e.g. renal parenchymal disease, renal artery stenosis) • Most monogenic causes of hypertension affect renal Na+ excretion • Salt intake is strongly linked with blood pressures of human populations. Populations with low salt have low population blood pressures and no rise in BP with age. • Animals with reduced renal Na+ handling (genetic or experimental) develop hypertension. Excess salt intake in many animals results in elevated blood pressure • In rats hypertension can be ‘transplanted’ with the kidney, there is similar, though incomplete data, in man Hypertension and the microvasculature: The retina illustrates microvascular damage in hypertension. There is thickening of the wall of small arteries, arteriolar narrowing, vasospasm, impaired perfusion and increased leakage into the surrounding tissue • Hypertrophy of the heart is likely to occur if the afterload (blood pressure) increases People eligible for Medicare Vital Statistics of the United States, NCHS 500 450 400 350 300 250 200 150 100 50 0 Stroke CHD CHF (per 100,000 pt years) CVD deaths (per 100,000 Population) Heart failure and CHF 3 2.5 Men Women Normal mesentery Hypertensive 2 1.5 • As one can see above, hypertension is associated with a reduction in capillary density. This may result in impaired perfusion and an increase in Peripheral Vascular Resistance. • Furthermore an elevated capillary pressure can cause damage and leakage which may put more strain on the lymphatic system and thus contribute to the development of oedema. 1 0.5 0 1994 1997 2000 2003 Hypertension and the kidneys: The prevalence of heart failure (CHF) is increasing (in contrast to other CVD) Hypertension increases the risk of CHF 2 -3 fold Hypertension probably accounts for about 25% of all cases of CHF Hypertension precedes CHF in 90% of cases The majority of CHF in the elderly is attributable to hypertension Hypertension & the kidney Renal dysfunction is common in hypertension (e.g. increased (micro)albumin excretion in urine). Extreme (accelerated/malignant hypertension) is now rare but leads to progressive renal failure Stuart's Cardiovascular System Page 41 Coronary Heart Disease 29 February 2012 08:59 Learning Objectives Appreciate the global and UK burden of coronary heart disease Appreciate the different clinical presentations of coronary heart disease Appreciate the global and UK burden of coronary heart disease Define myocardial ischaemia and its pathophysiology State the main cardiac factors which give rise to chest pain State the main clinical investigations that help diagnose angina State some of the drug treatments for angina Define thrombus, embolus, infarction Define Virchow's triad and compare/contrast the three elements State which of the triad has the dominant influence in arterial thrombosis Explain why thrombi are clinically important Describe the inciting events leading to infarction and the characteristics of infarctions, including the differences between red and white infarctions Outline the sequence of events following infarction and the factors that influence their development Describe the pathogenesis and clinical consequences of deep vein thrombosis and pulmonary embolism Describe pathogenesis and clinical consequences of fat embolism, gas embolism, and amniotic fluid embolism Myocardial Infarction: • Myocardial cell death arising from interrupted blood flow to the heart. ○ Coronary plaque rupture causes pro-thrombotic factors to be exposed. Therefore a thrombus can form and occlude the vessel. ○ Coronary plaque erosion. ○ Coronary dissection. • Mechanisms of myocardial cell death ○ Oncosis- Passive ischaemic cell death ○ Apoptosis Universal definition of Acute MI: • The term myocardial infarction should be used when there is evidence of myocardial necrosis in a clinical setting consistent with myocardial ischaemia. Under these conditions any of the following criteria meets the diagnosis for myocardial infarction: ○ Detection of rise and or fall of cardiac biomarkers (preferably troponin) with at least one value above the 99th percentile of the upper reference limit (URL) together with evidence of myocardial ischaemia with at least one of the following: Symptoms of ischaemia ECG changes indiciative of new ischaemia (new ST-T changes or new left bundle branch block) Development of pathological Q waves in the ECG. Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. Acute Coronary Syndromes Global Burden • Cardiovascular disease accounts for 17m deaths per year. • Leading cause of death in both developed and low/medium income countries. • Leading cause of death in age <70y. • Leading cause of death in women- risk factors were inappropriately recognized thought it was something else. UK Burden • 88,000 deaths per year due to CHD. • 18% of deaths in men and 10% deaths in women. • Mortality rates have reduced by about 40% however we still lag behind rest of Western Europe. • Main risks are use of tobacco, low physical activity, harmful use of alcohol and an unhealthy diet. These collectively result in hypertension, obesity, diabetes mellitus and hyperlipidaemia which are responsible for ~80% of CHD. Appreciate the different clinical presentations of coronary heart disease Sudden cardiac death o Acute coronary syndrome • Acute myocardial infarction • Unstable angina o Stable angina pectoris o Heart failure o Arrhythmia Stable Angina: • 2million individuals who suffer from it. • 45k admissions. • Angioplasty treats the symptoms rather than the cause. • 9-10 billion of healthcare money. Define myocardial ischaemia and its pathophysiology Mismatch between myocardial oxygen supply and demand. • Primary reduction in blood flow. • Inability to increase blood flow to match increased metabolic demand. • Prearterioles change diameter so that blood flow and pressure is maintained in arterioles themselves. • Arterioles within the myocardium are responsible for changing coronary resistance in response to myocardial oxygen demand. • Greater than 70% diameter stenosis in the pre-arterioles to alter coronary flow. • Greater than 50% diameter stenosis under situations of stress State the main cardiac factors which give rise to chest pain Angina Pectoris • This is a clinical diagnosis identified by discomfort in the chest, jaw, shoulder, arms or back. • It is provoked by exertion or emotional stress and can be relieved by rest of s.I GTN in <5min. • 20-30% plaque erosion • 70-80% plaque rupture. Define Virchow's triad and compare/contrast the three elements Virchow's triad- This consists of three important factors that contribute to thrombosis. • Abnormal vessel wall- Inflammation, atherosclerosis • Abnormal blood flow- Turbulent flow at bifurcations and stenoses, stasis. • Abnormal blood constituents- Hypercoagulability, abnormal platelet function, altered fibrinolysis, metabolic, hormonal factors. Specific causes of chest pain • Stenosis of blood vessels causing ischaemia. • Thrombus in vessels causing ischaemia. • Myocardial Infarction which caused by severe ischaemia. State the main clinical investigations that help diagnose angina • Functional tests- Is there myocardial ischaemia • Anatomical tests- Is there coronary narrowing. Endothelial dysfunction is also common to all three. State which of the triad has the dominant influence in arterial thrombosis • In arterial thrombosis the main factor is abnormal vessel wall resulting from atherosclerosis. Describe the inciting events leading to infarction and the characteristics of infarctions, including the differences between red and white infarctions Red and White Thrombus/Infarct White Red Stuart's Cardiovascular System Page 42 State some of the drug treatments for angina Red and White Thrombus/Infarct White Red Platelet rich Fibrin rich, with erythrocytes Common in arterial thrombosis (high pressure/turbulent circulation Common in venous or low pressure situations (stasis) Benefit from antiplatelet therapy Benefit from anticoagulant or antifibrinolytic therapy. State some of the drug treatments for angina • Improve blood supply: ○ Revascularization (PCI, CABG) ○ Vasodilators • Reduce myocardial oxygen demand ○ HR (beta blockers, Ca antagonists, If blockers) ○ Wall stress (ACE inhibitors, Ca antagonists) ○ Metabolic modifiers (Beta oxidation to Oxidative phosphorylation). • Prevent atherosclerosis progression and risk of death/MI. Manage Thrombotic Burden/ Risk • Necrosis passes as a wave front from endocardium outwards. • MI in absence of reperfusion has an infarct size of 70%. • Reperfusion reduces infarct size by 40% but part of remaining 30% infarct is due to lethal reperfusion injury and is therefore preventable. • When combined with cardioprotection the lethal reperfusion injury is reduced meaning that the infarct size is only 5%. Outline the sequence of events following infarction and the factors that influence their development Mechanisms underlying LV remodelling • Infarct thinning, elongation, expansion • LV dilatation • reduce wall tension • maintains cardiac output • Non-infarcted myocardium • LVH + myofilament dysfunction • Altered electromechanical coupling • Myocardial fibrosis • Apoptosis • Inflammation Consequences of Adverse LV Remodelling • • • • • • • Increased systolic wall tension/stress Increased MVO2 Reduced myocyte shortening Increased diastolic wall tension/stress Reduced subendocardial perfusion Dysynchronous depolarization/contraction Mitral regurgitation- valves aren't as effective thus some blood is able to leave which causes other problems • Ventricular arrhythmias • Ventricular fibrillation Describe pathogenesis and clinical consequences of fat embolism, gas embolism, and amniotic fluid embolism • Air embolism ○ Iatrogenic ○ Decompression sickness ○ Trauma • Fat embolism ○ Trauma • Amniotic fluid embolism ○ Pulmonary vascoconstriction, inflammation ○ ~1:54,000 deliveries, CFR 13-30% ○ Sudden CV collapse: Pulmonary HTN + RV failure -> LV failure ○ DIC ○ Rx: pulmonary vasodilators, FVIIa, ITU support • Cholesterol embolism ○ Showers of microemboli from within plaque of large calibre artery Stuart's Cardiovascular System Page 43 Describe the pathogenesis and clinical consequences of deep vein thrombosis and pulmonary embolism Embolism- An obstruction in a blood vessel due to a thrombus or other foreign matter that gets stuck while travelling through the bloodstream. • Arterial (ACS, TIA, stroke), air, fat, amniotic, foreign body/ material. • Venous (thrombus- DVT, PE) ○ Sudden CV collapse: Pulmonary HTN + RV failure -> LV failure ○ DIC ○ Rx: pulmonary vasodilators, FVIIa, ITU support • Cholesterol embolism ○ Showers of microemboli from within plaque of large calibre artery ○ Plaque rupture (spontaneous, traumatic, iatrogenic) ○ Embolization of plaque debris (cholesterol crystals, platelets, fibrin) ○ Lodging of emboli in arterioles 100-200μm diam. ○ Foreign body inflammatory response ○ End-organ damage due to microvascular plugging and inflammation Stuart's Cardiovascular System Page 44 • Stasis of blood flow. • POST DVT syndrome- venous ulceration, risk of infective ulcers around the limbs. Low molecular weight heparins. Integration of Responses to Haemorrhage 26 September 2012 22:22 Tutorial Scenario Central venous pressure low Less blood returning to heart – lower venous return Indicates low blood volume On admission 48 hrs later Pulse (beats/min) 120 75 BP (mmHg) 85/50 120/80 Central venous pressure (cm saline) -7 5 Haemoglobin (g/l) 130 83 Urea (mM/l) 5 12 Blood pressure Baroreceptor firing • Male with partially severed femoral artery. • On admission he was ○ Pale ○ Agitated ○ Thirsty ○ Cold extremities Stroke volume Cardiac output Parasymp. to heart Symp. to heart Mean BP = CO x TPR CO = HR x SV Symp. tone to blood vessels HR Force of contraction TPR Heart Rate Redistribution of blood flow – sympathetic vasoconstriction is not uniform • Increasing sympathetic action of the heart increases the heart rate by raising the gradient of the pre-potential of sino-atrial nodal cells, because they can achieve excitation quicker heart rate will be increased. Subject is pale and skin feels cold Blood flow to skin Blood flow to skeletal muscles Cerebral and cardiac blood flow unchanged Blood flow to gut Blood flow to kidney Angiotensinogen (liver) Low renal artery pressure renin AI ACE Aldosterone (adrenal cortex) Na retention AII Vasoconstrictor Thirst Contractility • Below is a schematic diagram of a nephron of the kidney. Note that the macula densa cells detect the decreased sodium levels which causes the juxtaglomerular cells to produce renin. • An increase in force of contraction is mediated by raised levels of cyclic AMP. Cyclic AMP helps to activate Protein Kinase A which synthesises and up regulates proteins needed for calcium entry and release within the cell. Total Peripheral Resistance • Both alpha and adrenoreceptors can have effects on the tone of the vascular smooth muscle. • In smooth muscles Calcium and Calmodulin complex activates Myosin light chain kinase. Low venous return Vessel damage Stuart's Cardiovascular System Page 45 Haemostatic mechanisms Left atrial pressure ADH secretion (post. pit) Low venous return Left atrial pressure Vessel damage ADH secretion (post. pit) Haemostatic mechanisms Kidney tubule permeability to water Preserve blood volume H2O reabsorption Volume replacement Low urine output Na retention Process of smooth muscle contraction via Myosin Light Chain Kinase: 1. Calcium ions either released from the sarcoplasmic reticulum via ryanodine receptors, or from the extracellular space bind to calmodulin. 2. This binding results in the activation of MLCK which phosphorylates the light chain of myosin at serine residue 19. 3. This phosphorylation enables a myosin and actin crossbridge to form and thus contraction to begin. • This pathway is particularly important because within smooth muscle fibres there is no troponin and thus this is the main mechanism of regulating contraction. • As we can see above the inositol triphosphate (IP3) that is expressed as a result of alpha adrenoreceptor activity will aid smooth muscle contraction and thus cause vasoconstriction. This is important in maintaining blood pressure. • Likewise the cAMP from B2- adrenoreceptors inhibits this process and will cause vasodilation. This is used to increase the blood flow to muscles during a sympathetic discharge. Lumen Size and Mechanics Volume Replacement • Crystalloid Solutions ○ Isotonic (0.9%) sodium chloride solution ○ Ringer's lactate • Colloids (Haemacel, Gelofusion) ○ These colloids have a high plasma oncotic pressure thus fluid isn't lost into ECF. • Blood products (if no response after infusion of 2 litres of crystalloid) ○ Packed red blood cells ○ Fresh Frozen Plasma (FFP) ○ Whole blood crossmatched Respiratory System • Chemoreceptors are chemosensitive cells sensitive to oxygen lack, CO 2 excess, or H+ ion excess. • Chemoreceptors are located in carotid bodies near the carotid bifurcation and on the arch of the aorta. • Activation of chemosensitive receptors results in excitation of the vasomotor centre. • Low levels of oxygen, high levels of CO2 and a drop in pH (increase in H+) results in the chemoreceptors firing and exciting the vasomotor centre. This then causes an increase in sympathetic activity and a raise in blood pressure. • Thus there are cardiovascular changes in response to respiratory needs. • As resistance is inversely proportional to the radius to the power of four, a small change in radius will result in a large change in resistance. • Since flow is the change in pressure divided by the resistance, the small change in pressure will have a large direct on the flow of blood passing through a vessel. Integration with other Systems Integration with other systems Physiological challenge renal response CVS response respiratory response Integrated response fluid, O2 and CO2 delivery and exchange Preservation of the internal environment SUCK ON THAT CVS!!!! 21st lecture boomed out Stuart's Cardiovascular System Page 46